10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from________ to ________

Commission File Number 1-32961

CBIZ, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation

or organization)

6050 Oak Tree Boulevard, South, Suite 500, Cleveland, Ohio

(Address of principal executive offices)

22-2769024

(I.R.S. Employer

Identification No.)

44131

(Zip Code)

(216) 447-9000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 Par Value	CBZ	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐    No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class of Common Stock	Outstanding at October 21, 2021
Common Stock, par value $0.01 per share	52,092,215

CBIZ, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

PART I.	FINANCIAL INFORMATION:		Page
	Item 1.	Condensed Consolidated Financial Statements (Unaudited)	3
		Condensed Consolidated Balance Sheets – September 30, 2021 and December 31, 2020	3
		Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended September 30, 2021 and 2020	4
		Condensed Consolidated Statements of Stockholders’ Equity – Three and Nine Months Ended September 30, 2021 and 2020	5
		Condensed Consolidated Statements of Cash Flows – Nine Months Ended September 30, 2021 and 2020	7
		Notes to the Condensed Consolidated Financial Statements	8
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	38
	Item 4.	Controls and Procedures	38
PART II.	OTHER INFORMATION:
	Item 1.	Legal Proceedings	40
	Item 1A.	Risk Factors	40
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	40
	Item 3.	Defaults Upon Senior Securities	41
	Item 4.	Mine Safety Disclosures	41
	Item 5.	Other Information	41
	Item 6.	Exhibits	42
	Signature		43

2

PART I – FINANCIAL INFORMATION

Item 1.    Financial Statements

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In thousands)

	September 30, 2021		December 31, 2020
ASSETS
Current assets:
Cash and cash equivalents	$	2,749	$	4,652
Restricted cash	37,320		23,951
Accounts receivable, net	293,890		216,175
Other current assets	25,694		24,213
Current assets before funds held for clients	359,653		268,991
Funds held for clients	175,451		167,440
Total current assets	535,104		436,431
Non-current assets:
Property and equipment, net	42,531		41,346
Goodwill and other intangible assets, net	843,246		756,750
Assets of deferred compensation plan	136,059		127,332
Operating lease right-of-use assets, net	152,131		147,843
Other non-current assets	3,697		4,052
Total non-current assets	1,177,664		1,077,323
Total assets	$	1,712,768	$	1,513,754
LIABILITIES
Current liabilities:
Accounts payable	$	75,607	$	64,119
Income taxes payable	7,971		2,788
Accrued personnel costs	96,924		79,978
Contingent purchase price liabilities	32,747		20,288
Operating lease liabilities	31,449		30,483
Other current liabilities	21,769		13,629
Current liabilities before client fund obligations	266,467		211,285
Client fund obligations	175,364		166,989
Total current liabilities	441,831		378,274
Non-current liabilities:
Bank debt	190,200		108,000
Debt issuance costs	(538)		(808)
Total long-term debt	189,662		107,192
Income taxes payable	1,836		1,775
Deferred income taxes, net	16,226		8,752
Deferred compensation plan obligations	136,059		127,332
Contingent purchase price liabilities	51,881		34,103
Operating lease liabilities	145,229		142,020
Other non-current liabilities	9,397		11,686
Total non-current liabilities	550,290		432,860
Total liabilities	992,121		811,134
STOCKHOLDERS' EQUITY
Common stock	1,351		1,341
Additional paid in capital	765,329		740,970
Retained earnings	638,382		557,875
Treasury stock	(683,217)		(595,297)
Accumulated other comprehensive loss	(1,198)		(2,269)
Total stockholders’ equity	720,647		702,620
Total liabilities and stockholders’ equity	$	1,712,768	$	1,513,754

See the accompanying notes to the unaudited condensed consolidated financial statements

3

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In thousands, except per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Revenue	$	282,719	$	238,389	$	862,097	$	752,787
Operating expenses	238,328		204,760		699,233		613,603
Gross margin	44,391		33,629		162,864		139,184
Corporate general and administrative expenses	13,035		11,339		41,334		32,988
Legal settlement, net	—		—		30,468		—
Operating income	31,356		22,290		91,062		106,196
Other income (expense):
Interest expense	(1,016)		(974)		(2,852)		(4,167)
Gain (loss) on sale of operations, net	—		(74)		6,385		78
Other (expense) income, net	(1,133)		5,914		12,029		3,450
Total other (expense) income, net	(2,149)		4,866		15,562		(639)
Income from continuing operations before income tax    expense	29,207		27,156		106,624		105,557
Income tax expense	7,512		7,060		26,100		27,120
Income from continuing operations	21,695		20,096		80,524		78,437
Loss from discontinued operations, net of tax	(4)		(19)		(17)		(44)
Net income	$	21,691	$	20,077	$	80,507	$	78,393
Earnings per share:
Basic:
Continuing operations	$	0.41	$	0.37	$	1.52	$	1.44
Discontinued operations	—		—		—		—
Net income	$	0.41	$	0.37	$	1.52	$	1.44
Diluted:
Continuing operations	$	0.41	$	0.36	$	1.50	$	1.41
Discontinued operations	—		—		—		—
Net income	$	0.41	$	0.36	$	1.50	$	1.41
Basic weighted average shares outstanding	52,425		54,403		52,885		54,372
Diluted weighted average shares outstanding	53,226		55,360		53,796		55,473
Comprehensive income:
Net income	$	21,691	$	20,077	$	80,507	$	78,393
Other comprehensive income (loss), net of tax	159		(186)		1,071		(1,815)
Comprehensive income	$	21,850	$	19,891	$	81,578	$	76,578

See the accompanying notes to the unaudited condensed consolidated financial statements

4

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

(In thousands)

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Totals
June 30, 2021	134,892	82,173	$	1,349	$	757,421	$	616,691	$	(661,772)	$	(1,357)	$	712,332
Net income	—	—	—		—		21,691		—		—		21,691
Other comprehensive income	—	—	—		—		—		—		159		159
Share repurchases	—	650	—		—		—		(21,445)		—		(21,445)
Stock options exercised	142	—	1		1,694		—		—		—		1,695
Stock-based compensation	—	—	—		2,905		—		—		—		2,905
Business acquisitions	99	—	1		3,309		—		—		—		3,310
September 30, 2021	135,133	82,823	$	1,351	$	765,329	$	638,382	$	(683,217)	$	(1,198)	$	720,647

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Totals
June 30, 2020	133,536	78,881	$	1,335	$	725,064	$	537,892	$	(566,762)	$	(2,309)	$	695,220
Net income	—	—	—		—		20,077		—		—		20,077
Other comprehensive loss	—	—	—		—		—		—		(186)		(186)
Share repurchases	—	165	—		—		—		(3,742)		—		(3,742)
Stock options exercised	115	—	2		1,490		—		—		—		1,492
Stock-based compensation	—	—	—		2,485		—		—		—		2,485
Business acquisitions	108	—	1		2,657		—		—		—		2,658
September 30, 2020	133,759	79,046	$	1,338	$	731,696	$	557,969	$	(570,504)	$	(2,495)	$	718,004

5

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

(In thousands)

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Totals
December 31, 2020	134,144	80,045	$	1,341	$	740,970	$	557,875	$	(595,297)	$	(2,269)	$	702,620
Net income	—	—	—		—		80,507		—		—		80,507
Other comprehensive income	—	—	—		—		—		—		1,071		1,071
Share repurchases	—	2,686	—		—		—		(84,883)		—		(84,883)
Indirect repurchase of shares for minimum tax withholding	—	92	—		—		—		(3,037)		—		(3,037)
Restricted stock units and awards	80	—	1		(1)		—		—		—		—
Stock options exercised	635	—	6		7,137		—		—		—		7,143
Stock-based compensation	—	—	—		8,359		—		—		—		8,359
Business acquisitions	274	—	3		8,864		—		—		—		8,867
September 30, 2021	135,133	82,823	$	1,351	$	765,329	$	638,382	$	(683,217)	$	(1,198)	$	720,647

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Totals
December 31, 2019	133,056	77,637	$	1,331	$	714,704	$	479,576	$	(535,693)	$	(680)	$	659,238
Net income	—	—	—		—		78,393		—		—		78,393
Other comprehensive loss	—	—	—		—		—		—		(1,815)		(1,815)
Share repurchases	—	1,312	—		—		—		(32,771)		—		(32,771)
Indirect repurchase of shares for minimum tax withholding	—	97	—		—		—		(2,040)		—		(2,040)
Restricted stock	40	—	—		—		—		—		—		—
Stock options exercised	442	—	5		4,714		—		—		—		4,719
Stock-based compensation	—	—	—		6,765		—		—		—		6,765
Business acquisitions	221	—	2		5,513		—		—		—		5,515
September 30, 2020	133,759	79,046	$	1,338	$	731,696	$	557,969	$	(570,504)	$	(2,495)	$	718,004

See the accompanying notes to the unaudited condensed consolidated financial statements

6

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In thousands)

	Nine Months Ended September 30,
	2021		2020
Cash flows from operating activities:
Net income	$	80,507	$	78,393
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	19,921		17,277
Gain on sale of operations, net	(6,385)		(78)
Bad debt expense, net of recoveries	562		3,166
Adjustment to contingent earnout liability	1,599		(80)
Stock-based compensation expense	8,359		6,765
Excess tax benefits from share based payment arrangements	(4,114)		(1,674)
Deferred income taxes	7,141		(1,809)
Other, net	(373)		388
Changes in assets and liabilities, net of acquisitions and divestitures:
Accounts receivable, net	(66,017)		(27,913)
Other assets	53		1,823
Accounts payable	12,126		(18,404)
Income taxes payable	9,359		12,048
Accrued personnel costs	15,329		(4,862)
Other liabilities	2,897		16,822
Operating cash flows provided by continuing operations	80,964		81,862
Operating cash flows used in discontinued operations	(18)		(66)
Net cash provided by operating activities	80,946		81,796
Cash flows from investing activities:
Business acquisitions and purchases of client lists, net of cash acquired	(66,155)		(33,782)
Purchases of client fund investments	(13,050)		(3,447)
Proceeds from the sales and maturities of client fund investments	10,800		32,967
Proceeds from sales of divested operations	9,785		651
Change in funds held for clients	(5,708)		3,250
Additions to property and equipment	(6,451)		(9,486)
Other, net	51		356
Net cash used in investing activities	(70,728)		(9,491)
Cash flows from financing activities:
Proceeds from bank debt	680,400		550,454
Payment of bank debt	(598,200)		(545,954)
Payment for acquisition of treasury stock	(84,950)		(32,083)
Indirect repurchase of shares for minimum tax withholding	(3,037)		(2,040)
Changes in client funds obligations	8,375		(57,517)
Proceeds from exercise of stock options	7,143		4,719
Payment of contingent consideration for acquisitions	(7,883)		(11,242)
Other, net	(170)		(395)
Net cash provided by (used in) financing activities	1,678		(94,058)
Net increase (decrease) in cash, cash equivalents and restricted cash	11,896		(21,753)
Cash, cash equivalents and restricted cash at beginning of year	170,335		146,505
Cash, cash equivalents and restricted cash at end of period	$	182,231	$	124,752
Reconciliation of cash, cash equivalents and restricted cash to the   Condensed Consolidated Balance Sheets:
Cash and cash equivalents	$	2,749	$	6,113
Restricted cash	37,320		25,275
Cash equivalents included in funds held for clients	142,162		93,364
Total cash, cash equivalents and restricted cash	$	182,231	$	124,752

See the accompanying notes to the unaudited condensed consolidated financial statements

7

CBIZ, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Selected Terms Used in Notes to the Condensed Consolidated Financial Statements

ASA – Administrative Service Agreement

ASC – Accounting Standards Codification

ASU – Accounting Standards Update

CECL– Current expected credit losses

CPA firm – Certified Public Accounting firm

FASB – The Financial Accounting Standards Board

GAAP – United States Generally Accepted Accounting Principles

LIBOR – London Interbank Offered Rate

SEC – United States Securities and Exchange Commission

Description of Business: CBIZ, Inc. is a diversified services company which, acting through its subsidiaries, has been providing professional business services since 1996, primarily to small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ, Inc. manages and reports its operations along three practice groups: Financial Services, Benefits and Insurance Services and National Practices. A further description of products and services offered by each of the practice groups is provided in Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements.

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries (“CBIZ”, the “Company”, “we”, “us”, or “our”), after elimination of all intercompany balances and transactions. These unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations or cash flows of CBIZ.

Unaudited Interim Financial Statements: The condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2021.

Use of Estimates: The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

8

NOTE 2. NEW ACCOUNTING PRONOUNCEMENTS

The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an accounting standard to communicate changes to the FASB codification. We assess and review the impact of all accounting standards. Any accounting standards not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements of the Company.

Accounting Standards Issued But Not Yet Adopted

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities through December 31, 2022. We are currently evaluating the effect of this new standard on our consolidated financial statements and have not adopted any of the transition relief available under the new guidance as of September 30, 2021.

Subsequently, in January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which provides optional temporary guidance for entities transitioning away from the LIBOR and other interbank offered rates to new reference rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. This ASU clarifies that the derivative instruments affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions provided in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments provided in this ASU do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship. We are currently evaluating the effect of this new standard on our consolidated financial statements and have not adopted any of the transition relief available under the new guidance as of September 30, 2021.

NOTE 3. ACCOUNTS RECEIVABLE, NET

Accounts receivable, less allowance for doubtful accounts, reflects the net realizable value of receivables and approximates fair value. Unbilled revenue is recorded at estimated net realizable value. Assessing the collectability of the receivables (billed and unbilled) requires management judgment based on a combination of factors, including but not limited to, an evaluation of our historical incurred loss experience, credit-worthiness of our clients, age of the trade receivable balance, current economic conditions that may affect a client’s ability to pay, and reasonable and supportable forecasts. Receivables are charged-off against the allowance when the balance is deemed uncollectible.

Accounts receivable, net, at September 30, 2021 and December 31, 2020 was as follows (in thousands):

	September 30, 2021		December 31, 2020
Trade accounts receivable	$	200,584	$	167,575
Unbilled revenue, at net realizable value	107,664		63,494
Total accounts receivable	308,248		231,069
Allowance for doubtful accounts	(14,358)		(14,894)
Accounts receivable, net	$	293,890	$	216,175

9

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2021 and twelve months ended December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Balance at beginning of period	$	(14,894)	$	(14,379)
Provision	(4,450)		(9,323)
Charge-offs, net of recoveries	4,986		8,808
Allowance for doubtful accounts	$	(14,358)	$	(14,894)

NOTE 4. DEBT AND FINANCING ARRANGEMENTS

2018 Credit Facility - Our primary financing arrangement is the $400 million unsecured credit facility (the “2018 credit facility” or the “credit facility”), which provides us with the capital necessary to meet our working capital needs as well as the flexibility to continue with our strategic initiatives, including business acquisitions and share repurchases. The 2018 credit facility matures in 2023. The balance outstanding under the 2018 credit facility was $190.2 million and $108.0 million at September 30, 2021 and December 31, 2020, respectively. Effective interest rates, including the impact of interest rate swaps associated with the 2018 credit facility, were as follows:

	Nine Months Ended September 30,
	2021	2020
Weighted average rates	1.89%	2.46%
Range of effective rates	1.06% - 3.64%	1.10% - 4.75%

We had approximately $201.6 million of available funds under the credit facility at September 30, 2021, net of outstanding letters of credit of $3.4 million. As of September 30, 2021, we were in compliance with our financial debt covenants.

Other Line of Credit - We have an unsecured $20.0 million line of credit by and among CBIZ Benefits and Insurance, Inc. and Huntington National Bank. We utilize this line to support our short-term funding requirements of payroll client fund obligations due to the investment of client funds, rather than liquidating client funds that have already been invested in available-for-sale securities. The line of credit, which was renewed on August 5, 2021 and will terminate on August 4, 2022, did not have a balance outstanding at September 30, 2021.

Refer to our Annual Report on Form 10-K for the year ended December 31, 2020 for additional details of our debt and financing arrangements.

Interest Expense - Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, was as follows (in thousands):

	Three Months Ended September 30,
	2021		2020
2018 credit facility	$	1,010	$	955
Other	6		19
Total	$	1,016	$	974

	Nine Months Ended September 30,
	2021		2020
2018 credit facility	$	2,833	$	4,112
Other line of credit	—		1
Other	19		54
Total	$	2,852	$	4,167

10

NOTE 5. COMMITMENTS AND CONTINGENCIES

Letters of Credit and Guarantees - We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $3.4 million and $1.7 million at September 30, 2021 and December 31, 2020, respectively. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.3 million and $2.2 million at September 30, 2021 and December 31, 2020, respectively.

Legal Proceedings - In 2010, CBIZ, Inc. and its subsidiary, CBIZ MHM, LLC (formerly, CBIZ Accounting, Tax & Advisory Services, LLC) (the “CBIZ Parties”), were named as defendants in lawsuits filed in the U.S. District Court for the District of Arizona and the Superior Court for Maricopa County, Arizona. The federal court case is captioned Robert Facciola, et al v. Greenberg Traurig LLP, et al, and the state court cases are captioned Victims Recovery, LLC v. Greenberg Traurig LLP, et al, Roger Ashkenazi, et al v. Greenberg Traurig LLP, et al, Mary Marsh, et al v. Greenberg Traurig LLP, et al; and ML Liquidating Trust v. Mayer Hoffman McCann, P.C. (“Mayer Hoffman”), et al. Prior to these suits CBIZ MHM, LLC was named as a defendant in Jeffrey C. Stone v. Greenberg Traurig LLP, et al.

These lawsuits arose out of the bankruptcy of Mortgages Ltd., a mortgage lender to developers in the Phoenix, Arizona area. Various other professional firms and individuals not related to the Company were also named defendants in these lawsuits. The lawsuits asserted claims for, among others things, violations of the Arizona Securities Act, common law fraud, and negligent misrepresentation, and sought to hold the CBIZ Parties vicariously liable for Mayer Hoffman’s conduct as Mortgage Ltd.’s auditor, as either a statutory control person under the Arizona Securities Act or a joint venturer under Arizona common law.

On September 27, 2021, the Superior Court for Maricopa County, Arizona, granted the CBIZ Parties' motion to dismiss with prejudice all of the remaining claims being pursued by two plaintiffs from the Ashkenazi lawsuit. Therefore, all litigation related to these matters has been dismissed or settled without payment by the CBIZ Parties.

On December 19, 2016, CBIZ Operations, Inc. (“CBIZ Operations”) was named as a defendant in a lawsuit filed by Zotec Partners, LLC (“Zotec”) in the Marion County Indiana Superior Court.  After various amendments, the lawsuit asserts claims under Indiana law for securities, statutory and common law fraud or deception, unjust enrichment, breach of contract, and vicarious liability against CBIZ Operations and a former employee of CBIZ MMP in connection with the sale of the CBIZ MMP medical billing practice to Zotec. The plaintiff claims that CBIZ Operations had a duty to disclose the fact, unknown to employees of CBIZ Operations at the time of the transaction, that the former employee had a financial arrangement with a Zotec vendor at the time CBIZ Operations sold CBIZ MMP to Zotec. The plaintiff is seeking damages of up to $177.0 million out of the $200.0 million transaction price. Trial was held in October 2021. The jury found in favor of CBIZ on all fraud, contract and other claims before it. Zotec’s remaining claim for Indiana statutory securities fraud and CBIZ’s counterclaim for breach of contract against Zotec will be addressed by the trial Judge at a later date.

We cannot predict the outcome of the above matter or estimate the possible loss or range of possible loss, if any. Although the proceeding is subject to uncertainties inherent in the litigation process and the ultimate disposition of this proceeding is not presently determinable, we intend to vigorously defend this case. In addition to those items disclosed above, we are, from time to time, subject to claims and lawsuits arising in the ordinary course of business.

On June 24, 2021, CBIZ settled the case previously brought by UPMC, d/b/a University of Pittsburgh Medical Center, and a health system it acquired in connection with actuarial services provided by the Company. Under the terms of the settlement, CBIZ paid a total settlement amount of $41.5 million and recorded a settlement loss of $30.5 million.

NOTE 6. FINANCIAL INSTRUMENTS

Available-For-Sale Debt Securities - In connection with certain services provided by our payroll operations, we collect funds from our clients’ accounts in advance of paying client obligations. These funds held for clients are segregated and invested in accordance with our investment policy, which requires all investments carry an investment grade rating at the time of initial investment. These

11

investments, primarily consisting of corporate and municipal bonds, are classified as available-for-sale and are included in the “Funds held for clients” line item on the accompanying Condensed Consolidated Balance Sheets. The par value of these investments totaled $27.1 million and $24.9 million at September 30, 2021 and December 31, 2020, respectively, and had maturity or callable dates ranging from October 2021 through November 2025.

At September 30, 2021, unrealized losses on the securities were not material and have not been recognized as a credit loss because the bonds are investment grade quality and management is not required or does not intend to sell prior to an expected recovery in value. The bond issuers continue to make timely principal and interest payments.

The following table summarizes activities related to these investments for the nine months ended September 30, 2021 and the twelve months ended December 31, 2020 (in thousands):

	Nine Months Ended September 30, 2021		Twelve Months Ended December 31, 2020
Fair value at beginning of period	$	25,708	$	60,659
Purchases	13,050		3,447
Redemptions	(6,280)		(22,078)
Maturities	(4,520)		(15,409)
Change in bond premium	874		(857)
Fair market value adjustment	(377)		(54)
Fair value at end of period	$	28,455	$	25,708

In addition to the available-for-sale debt securities discussed above, we also held other depository assets in the amount of $4.8 million as of September 30, 2021. We did not have any depository items at December 31, 2020. Those depository assets are classified as Level 1 in the fair value hierarchy.

Interest Rate Swaps - We utilize interest rate swaps to manage interest rate risk exposure associated with our floating-rate debt under the 2018 credit facility, or the forecasted acquisition of such liability. We do not purchase or hold any derivative instruments for trading or speculative purposes. Refer to the Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion on our interest rate swaps.

During the first quarter of 2021, one interest rate swap expired with a notional value of $10.0 million. As of September 30, 2021, we have three interest rate swaps outstanding. Under the terms of the interest rate swaps, we pay interest at a fixed rate of interest plus applicable margin as stated in the agreement, and receive interest that varies with the one-month LIBOR. The notional value, fixed rate of interest and expiration date of each interest rate swap as of September 30, 2021 was (i) $20.0 million – 1.770% - May 2022, (ii) $15.0 million – 2.640% - June 2023 and (iii) $50.0 million - 0.885% - April 2025. Refer to Note 7, Fair Value Measurements, for additional disclosures regarding fair value measurements.

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying Condensed Consolidated Balance Sheets at September 30, 2021 and December 31, 2020 (in thousands):

	September 30, 2021
	Notional Amount		Fair Value		Balance Sheet Location
Interest rate swap	$	20,000	$	(211)	Other current liability
Interest rate swaps	$	65,000	$	(575)	Other non-current liabilities

	December 31, 2020
	Notional Amount		Fair Value		Balance Sheet Location
Interest rate swap	$	10,000	$	(13)	Other current liability
Interest rate swaps	$	85,000	$	(2,552)	Other non-current liabilities

12

The following table summarizes the effects of the interest rate swaps on the accompanying Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2021 and 2020 (in thousands):

	Gain (Loss) Recognized in AOCL, net of tax				Loss Reclassified from AOCL into Expense
	Three Months Ended September 30,				Three Months Ended September 30,
	2021		2020		2021		2020
Interest rate swaps	$	66	$	(136)	$	(285)	$	(293)

	Nine Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Interest rate swaps	$	718	$	(1,796)	$	(850)	$	(676)

NOTE 7. FAIR VALUE MEASUREMENTS

The following table summarizes our assets and (liabilities) at September 30, 2021 and December 31, 2020, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

	Level	September 30, 2021		December 31, 2020
Deferred compensation plan assets	1	$	136,059	$	127,332
Available-for-sale debt securities	1	28,455		25,708
Other depository assets	1	4,834		—
Deferred compensation plan liabilities	1	(136,059)		(127,332)
Interest rate swaps	2	(786)		(2,565)
Contingent purchase price liabilities	3	(84,628)		(54,391)

During the nine months ended September 30, 2021 and 2020, there were no transfers between the valuation hierarchy Levels 1, 2 and 3. The following table summarizes the change in Level 3 fair values of our contingent purchase price liabilities for the nine months ended September 30, 2021 and 2020 (pre-tax basis) (in thousands):

	2021		2020
Beginning balance – January 1	$	(54,391)	$	(32,089)
Additions from business acquisitions	(38,149)		(14,953)
Settlement of contingent purchase price liabilities	9,511		12,854
Change in fair value of contingencies	(336)		612
Change in net present value of contingencies	(1,263)		(532)
Ending balance – September 30	$	(84,628)	$	(34,108)

Contingent purchase price liabilities result from our business acquisitions and are recorded at fair value at the time of acquisition and are presented as “Contingent purchase price liabilities — current” and “Contingent purchase price liabilities — non-current” in the accompanying Condensed Consolidated Balance Sheets. We estimate the fair value of our contingent purchase price liabilities using a probability-weighted discounted cash flow model. This fair value measure is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Fair value measurements characterized within Level 3 of the fair value hierarchy are measured based on unobservable inputs that are supported by little or no market activity and reflect our own assumptions in measuring fair value.

We probability weight risk-adjusted estimates of future performance of acquired businesses, then calculate the contingent purchase price based on the estimates and discount them to present value representing management’s best estimate of fair value. The fair value of the contingent purchase price liabilities is reassessed quarterly based on assumptions provided by practice group leaders and

13

business unit controllers together with our corporate finance department. Any change in the fair value estimate is recorded in the earnings of that period. Refer to Note 11, Business Combinations, for further discussion of our acquisitions and contingent purchase price liabilities.

The carrying amounts of our cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short maturity of these instruments, and the carrying value of bank debt approximates fair value as the interest rate on the bank debt is variable and approximates current market rates. As a result, the fair value measurement of our bank debt is considered to be Level 2.

NOTE 8. OTHER COMPREHENSIVE INCOME (LOSS)

The following table is a summary of other comprehensive income (loss) and discloses the tax impact of each component of other comprehensive income (loss) for the three and nine months ended September 30, 2021 and 2020 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net unrealized loss on available-for-sale    securities, net of income taxes (1)	$	(116)	$	(46)	$	(274)	$	(1)
Net unrealized gain (loss) on interest rate swaps, net of income taxes (2)	281		(136)		1,359		(1,796)
Foreign currency translation	(6)		(4)		(14)		(18)
Total other comprehensive income (loss)	$	159	$	(186)	$	1,071	$	(1,815)

(1)Net of income tax benefit of $44 and $17 for the three months ended September 30, 2021 and 2020, respectively, and net of income tax benefit of $103 and income tax expense of $2 for the nine months ended September 30, 2021 and 2020, respectively.

(2)Net of income tax expense of $90 and income tax benefit of $45 for the three months ended September 30, 2021 and 2020, respectively, and net of income tax expense of $436 and income tax benefit of $579 for the nine months ended September 30, 2021 and 2020, respectively.

NOTE 9. EMPLOYEE STOCK PLANS

The 2019 Stock Omnibus Incentive Plan (the “2019 Plan”), which expires in 2029, permits the grant of various forms of stock-based awards. The terms and vesting schedules for the stock-based awards vary by type and date of grant. A maximum of 3.1 million stock options, restricted stock or other stock-based compensation awards may be granted. Shares subject to award under the 2019 Plan may be either authorized but unissued shares of our common stock or treasury shares. Refer to the Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion on the 2019 Plan.

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2021 and 2020 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Stock options	$	581	$	615	$	1,114	$	1,403
Restricted stock units and awards	1,388		1,266		4,214		3,761
Performance share units	936		604		3,031		1,601
Total stock-based compensation expense	$	2,905	$	2,485	$	8,359	$	6,765

Stock Options and Restricted Stock Units and Awards – The following table presents our stock options and restricted stock units and awards activity during the nine months ended September 30, 2021 (in thousands, except per share data):

14

	Stock Options			Restricted Stock Units and Awards
	Number of Options	Weighted Average Exercise Price Per Share		Number of Shares	Weighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year	1,820	$	15.02	461	$	21.03
Granted	50	$	32.64	174	$	28.62
Exercised or released	(635)	$	11.25	(246)	$	20.00
Expired or canceled	—	$	—	—	$	—
Outstanding at September 30, 2021	1,235	$	17.68	389	$	25.07
Exercisable at September 30, 2021	1,087	$	17.43

(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

CBIZ utilized the Black-Scholes-Merton options pricing model to determine the fair value of stock options on the date of grant. The per-share fair value of stock options granted on August 12, 2021 was $8.10. The following weighted average assumptions were utilized:

	Nine Months Ended September 30, 2021
Expected volatility (1)	27.49%
Expected option life (years) (2)	4.71
Risk-free interest rate (3)	0.74%
Expected dividend yield (4)	—%

(1) The expected volatility assumption was determined based upon the historical volatility of CBIZ's stock price using daily price intervals.

(2) The expected option life was determined based upon CBIZ's historical data using a midpoint scenario, which assumes all options are exercised halfway between the expiration date and the weighted average time it takes the option to vest.

(3) The risk-free interest rate assumption was based upon zero-coupon U.S. treasury bonds with a term approximating the expected life of the respective options.

(4) The expected dividend yield assumption was determined in view of CBIZ's historical and estimated dividend payouts. CBIZ does not expect to change its dividend payout policy in the foreseeable future.

Performance Share Units (“PSUs”) – PSUs are earned based on our financial performance over a contractual term of three years and the associated expense is recognized over that period based on the fair value of the award. A three-year cliff vesting schedule of the PSUs is dependent upon the Company’s performance relative to pre-established goals based on an earnings per share target (weighted 70%) and total growth in revenue (weighted 30%). The fair value of PSUs is calculated using the market value of a share of our common stock on the date of grant. For performance achieved above specified levels, the recipient may earn additional shares of stock, not to exceed 200% of the number of PSUs initially granted.

The following table presents our PSU award activity during the nine months ended September 30, 2021 (in thousands, except per share data):

15

	Performance Share Units	Weighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year	307	$	22.18
Granted	140	$	27.56
Vested	—	$	—
Adjustments for performance results	—	$	—
Canceled	—	$	—
Outstanding at September 30, 2021	447	$	23.86

(1)Represents weighted average market value of the performance share units; PSUs are granted at no cost to the recipients.

NOTE 10. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share from continuing operations for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data).

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Numerator:
Income from continuing operations	$	21,695	$	20,096	$	80,524	$	78,437
Denominator:
Basic
Weighted average common shares outstanding	52,425		54,403		52,885		54,372
Diluted
Stock options (1)	609		738		692		825
Restricted stock units and awards (1)	155		135		182		192
Contingent shares (2)	37		84		37		84
Diluted weighted average common shares    outstanding (3)	53,226		55,360		53,796		55,473
Basic earnings per share from continuing operations	$	0.41	$	0.37	$	1.52	$	1.44
Diluted earnings per share from continuing operations	$	0.41	$	0.36	$	1.50	$	1.41

(1)A total of 44 thousand and 106 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021, respectively, and a total of 274 thousand and 240 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2020, respectively, as their effect would be anti-dilutive.

(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future considerations have been met. Refer to Note 11, Business Combinations, for further details.

(3)The denominator used in calculating diluted earnings per share did not include 447 thousand performance share units for both the three and nine months ended September 30, 2021, and the denominator used in calculating diluted earnings per share did not include 324 thousand performance share units for both the three and nine months ended September 30, 2020. The performance conditions associated with these performance share units were not met and consequently none of these performance share units were considered as issuable for the three and nine months ended September 30, 2021 and 2020.

16

NOTE 11. BUSINESS COMBINATIONS

Business Combinations

During the nine months ended September 30, 2021, we completed the following acquisitions:

•Effective January 1, 2021, we acquired substantially all the assets of Middle Market Advisory Group (“MMA”). MMA, based in Englewood, Colorado, is a provider of tax compliance and consulting services to middle market companies and family groups in the real estate, automotive, technology and SAAS, construction, and manufacturing industries. Operating results are reported in the Financial Services practice group.

•Effective April 1, 2021, we acquired substantially all the assets of Wright Retirement Services, LLC ("Wright"). Wright, located in Valdosta, Georgia, specializes in third party administration services for retirement plan sponsors. Operating results are reported in the Benefits and Insurance practice group.

•Effective May 1, 2021, we acquired substantially all of the non-attest assets of Bernston Porter & Company, PLLC ("BP"). BP, based in Bellevue, Washington, is a provider of comprehensive accounting and financial consulting services including tax, forensic, economic and valuation services and transaction services to a wide range of industries with specialities including construction, real estate, hospitality, manufacturing and technology. Operating results are reported in the Financial Services practice group.

•Effective June 1, 2021, we acquired all of the issued and outstanding membership interests of Schramm Health Partners, LLC dba Optumas ("Optumas"). Optumas, based in Scottsdale, Arizona, is a provider of actuarial services to state government health care agencies to assist in the administration of Medicaid programs. Operating results are reported in the Financial Services practice group.

•Effective September 1, 2021, we acquired all of the non-attest assets of Shea Labagh Dobberstein ("SLD"). SLD, based in San Francisco, California, is a provider of professional accounting, tax and advisory services to privately held businesses, individuals and nonprofit organizations. Operating results are reported in the Financial Services practice group.

During the nine months ended September 30, 2020, we completed the following acquisitions:

•Effective February 1, 2020, we acquired substantially all the assets of Alliance Insurance Services, Inc., a provider of insurance and advisory services based in Washington, DC. Operating results are reported in the Benefits and Insurance Services practice group.

•Effective February 1, 2020, we acquired substantially all the assets of Pension Dynamics Company, LLC, a full-service retirement and benefits plan advisor based in Pleasant Hill, California. Operating results are reported in the Benefits and Insurance Services practice group.

•Effective February 1, 2020, we acquired substantially all the assets of Sunshine Systems, a payroll solutions provider based in Massachusetts. Operating results are reported in the Benefits and Insurance Services practice group.

•Effective July 1, 2020, we acquired substantially all the assets of Prince-Wood Insurance, LLC, a provider of financial, insurance and advisory services based in Woodbridge, Virginia. Operating results are reported in the Benefits and Insurance practice group.

•Effective September 1, 2020, we acquired substantially all the assets of ARC Consulting LLC and ARC Placement Group LLC, a provider of financial, insurance and advisory services based in San Francisco, California. Operating results are reported in the Financial Services practice group.

Aggregated annualized revenue is estimated to be approximately $71.9 million and $24.6 million from the aforementioned 2021 and 2020 acquisitions, respectively. Aggregated annualized income before tax is estimated to be approximately $6.1 million and $5.9 million from the aforementioned 2021 and 2020 acquisitions, respectively. Pro forma results of operations for these acquisitions have not been presented because the effects of these acquisitions were not material, either individually or in

17

aggregate, to our total revenue, income from continuing operations, and net income for the three and nine months ended September 30, 2021 and 2020, respectively.

The following table summarizes the aggregated consideration and preliminary purchase price allocation for the acquisitions completed during the nine months ended September 30, 2021 and 2020, respectively (in thousands):

	2021		2020
Common Stock Issued (number)	207		141
Common Stock Value	$	6,940	$	3,543
Cash Paid	66,051		35,474
Other Payable	—		59
Recorded Contingent Consideration	38,148		16,237
Total Recorded Purchase Price	$	111,139	$	55,313
Other Assets Acquired, net	10,179		1,940
Identifiable Intangible Assets Acquired	40,753		4,807
Goodwill	60,207		48,565
Total Net Assets Acquired	$	111,139	$	55,312
Maximum Potential Contingent Consideration	$	40,126	$	18,736

Provisional estimates of fair value are established at the time of each acquisition and are subsequently reviewed within the first year of operations subsequent to the acquisition date to determine the necessity for adjustments. Fair value estimates were provisional for some of the 2021 acquisitions as of September 30, 2021, primarily related to the value established for certain identifiable intangible assets and contingent purchase price consideration associated with those acquisitions.

The following table summarizes the aggregated goodwill and intangible asset amounts resulting from those acquisitions for the nine months ended September 30, 2021 and 2020, respectively (in thousands):

	Nine Months Ended September 30,
	2021				2020
	Financial Services		Benefits & Insurance		Financial Services		Benefits & Insurance
Goodwill	$	58,409	$	1,798	$	34,766	$	13,799
Client List	38,580		1,290		—		4,070
Other Intangibles	837		46		504		233
Total	$	97,826	$	3,134	$	35,270	$	18,102

Goodwill is calculated as the difference between the aggregated purchase price and the fair value of the net assets acquired. Goodwill represents the value of expected future earnings and cash flows, as well as the synergies created by the integration of the new businesses within our organization, including cross-selling opportunities expected with our Financial Services practice group and the Benefits and Insurance Services practice group, to help strengthen our existing service offerings and expand our market position. Client lists have an expected life of 10 years, and other intangibles, primarily non-compete agreements, have an expected life of 3 years.

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and continent payments made for previous business acquisitions in the three and nine months ended September 30, 2021 and 2020, respectively (in thousands):

18

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net Expense (Income)	$	846	$	74	$	1,599	$	(80)
Cash Settlement Paid	$	—	$	4,995	$	7,584	$	10,881
Shares Issued (number)	13		0		66		81

Divestitures

Divested operations and assets that do not qualify for the treatment as discontinued operations are recorded as “gain on sale of operations, net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. During the nine months ended September 30, 2021, we sold one business for $9.7 million in the Benefit and Insurance practice group and recorded a gain of $6.4 million.

During the nine months ended September 30, 2020, we recorded a gain of $0.1 million related to a small book of business in the Benefits and Insurance practice group and a small accounting firm in the Financial Services practice group.

NOTE 12. SEGMENT DISCLOSURES

Our business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services and National Practices. The business units have been aggregated based on the following factors: similarity of the products and services provided to clients; similarity of the regulatory environment in which they operate; and similarity of economic conditions affecting long-term performance. The business units are managed along these segment lines. A general description of services provided by each practice group is provided in the table below.

Financial Services	Benefits and Insurance Services	National Practices
Accounting and Tax	Group Health Benefits Consulting	Managed Networking and Hardware Services
Government Healthcare Consulting	Payroll	Healthcare Consulting
Financial Advisory	Property and Casualty
Valuation	Retirement Plan Services
Risk & Advisory Services

Corporate and Other - Included in “Corporate and Other” are operating expenses that are not directly allocated to the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in our non-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs and other various expenses.

Accounting policies of the practice groups are the same as those described in Note 1, Basis of Presentation and Significant Accounting Policies, to the Annual Report on Form 10-K for the year ended December 31, 2020. Upon consolidation, intercompany accounts and transactions are eliminated, thus inter-segment revenue is not included in the measure of profit or loss for the practice groups. Performance of the practice groups is evaluated on income (loss) from continuing operations before income tax expense (benefit) excluding those costs listed above, which are reported as “Corporate and Other”.

Segment information for the three and nine months ended September 30, 2021 and 2020 is presented below. We do not manage our assets on a segment basis, therefore segment assets are not presented below.

19

The following table disaggregates our revenue by source (in thousands):

	Three Months Ended September 30, 2021
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	187,232	—		—		$	187,232
Core benefits and insurance services	—		83,009		—		83,009
Non-core benefits and insurance services	—		2,788		—		2,788
Managed networking, hardware services	—		—		7,088		7,088
National practices consulting	—		—		2,602		2,602
Total revenue	$	187,232	$	85,797	$	9,690	$	282,719

	Three Months Ended September 30, 2020
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	155,499	—		—		$	155,499
Core benefits and insurance services	—		71,497		—		71,497
Non-core benefits and insurance services	—		2,384		—		2,384
Managed networking, hardware services	—		—		6,592		6,592
National practices consulting	—		—		2,417		2,417
Total revenue	$	155,499	$	73,881	$	9,009	$	238,389

	Nine Months Ended September 30, 2021
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	577,970	—		—		$	577,970
Core benefits and insurance services	—		246,367		—		246,367
Non-core benefits and insurance services	—		9,289		—		9,289
Managed networking, hardware services	—		—		20,952		20,952
National practices consulting	—		—		7,519		7,519
Total revenue	$	577,970	$	255,656	$	28,471	$	862,097

	Nine Months Ended September 30, 2020
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	498,359	—		—		$	498,359
Core benefits and insurance services	—		219,362		—		219,362
Non-core benefits and insurance services	—		8,071		—		8,071
Managed networking, hardware services	—		—		19,748		19,748
National practices consulting	—		—		7,247		7,247
Total revenue	$	498,359	$	227,433	$	26,995	$	752,787

20

Segment information for the three months ended September 30, 2021 and 2020 was as follows (in thousands):

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	187,232	$	85,797	$	9,690	$	—	$	282,719
Operating expenses	156,178		69,039		8,514		4,597		238,328
Gross margin	31,054		16,758		1,176		(4,597)		44,391
Corporate general and administrative expenses	—		—		—		13,035		13,035
Operating income (loss)	31,054		16,758		1,176		(17,632)		31,356
Other income (expense):
Interest expense	—		—		—		(1,016)		(1,016)
Other income (expense), net	18		(9)		1		(1,143)		(1,133)
Total other income (expense), net	18		(9)		1		(2,159)		(2,149)
Income (loss) from continuing operations before income tax expense	$	31,072	$	16,749	$	1,177	$	(19,791)	$	29,207

	Three Months Ended September 30, 2020
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	155,499	$	73,881	$	9,009	$	—	$	238,389
Operating expenses	129,922		62,013		8,070		4,755		204,760
Gross margin	25,577		11,868		939		(4,755)		33,629
Corporate general and administrative expenses	—		—		—		11,339		11,339
Operating income (loss)	25,577		11,868		939		(16,094)		22,290
Other income (expense):
Interest expense	—		(10)		—		(964)		(974)
Gain (loss) on sale of operations, net	(76)		2		—		—		(74)
Other (expense) income, net	(14)		(36)		—		5,964		5,914
Total other (expense) income, net	(90)		(44)		—		5,000		4,866
Income (loss) from continuing operations before income tax expense	$	25,487	$	11,824	$	939	$	(11,094)	$	27,156

21

Segment information for the nine months ended September 30, 2021 and 2020 was as follows (in thousands):

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	577,970	$	255,656	$	28,471	$	—	$	862,097
Operating expenses	448,844		203,748		25,542		21,099		699,233
Gross margin	129,126		51,908		2,929		(21,099)		162,864
Corporate general and administrative expenses	—		—		—		41,334		41,334
Legal settlement, net							30,468		30,468
Operating income (loss)	129,126		51,908		2,929		(92,901)		91,062
Other income (expense):
Interest expense	—		—		—		(2,852)		(2,852)
Gain on sale of operations, net	—		6,385		—		—		6,385
Other income, net	310		863		1		10,855		12,029
Total other income, net	310		7,248		1		8,003		15,562
Income (loss) from continuing operations before income tax expense	$	129,436	$	59,156	$	2,930	$	(84,898)	$	106,624

	Nine Months Ended September 30, 2020
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	498,359	$	227,433	$	26,995	$	—	$	752,787
Operating expenses	395,937		188,519		24,343		4,804		613,603
Gross margin	102,422		38,914		2,652		(4,804)		139,184
Corporate general and administrative expenses	—		—		—		32,988		32,988
Operating income (loss)	102,422		38,914		2,652		(37,792)		106,196
Other (expense) income:
Interest expense	—		(30)		—		(4,137)		(4,167)
Gain (loss) on sale of operations, net	(25)		103		—		—		78
Other income, net	32		190		1		3,227		3,450
Total other income (expense), net	7		263		1		(910)		(639)
Income (loss) from continuing operations before income tax expense	$	102,429	$	39,177	$	2,653	$	(38,702)	$	105,557

NOTE 13. SUBSEQUENT EVENTS

Subsequent to September 30, 2021 we repurchased approximately 0.3 million shares of our common stock in the open market at a total cost of approximately $9.0 million.

22

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to “we”, “us”, “our”, "CBIZ" or the "Company" shall mean CBIZ, Inc., a Delaware corporation, and its operating subsidiaries.

The following discussion is intended to assist in the understanding of our financial position at September 30, 2021 and December 31, 2020, results of operations for the three and nine months ended September 30, 2021 and 2020, and cash flows for the nine months ended September 30, 2021 and 2020, and should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and with our Annual Report on Form 10-K for the year ended December 31, 2020. This discussion and analysis contains forward-looking statements and should also be read in conjunction with the disclosures and information contained in “Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q and in “Item 1A. Risk Factors” included in the Annual Report on Form 10-K for the year ended December 31, 2020.

OVERVIEW

We provide professional business services, products and solutions that help our clients grow and succeed by better managing their finances and employees. These services are provided to businesses of various sizes, as well as individuals, governmental entities and not-for-profit enterprises throughout the United States and parts of Canada. We deliver integrated services through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. Refer to Note 12, Segment Disclosures, to the accompanying condensed consolidated financial statements for a general description of services provided by each practice group.

Refer to the Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion of our business and strategies, as well as the external relationships and regulatory factors that currently impact our operations.

EXECUTIVE SUMMARY

Revenue for the three months ended September 30, 2021 increased by $44.3 million, or 18.6%, to $282.7 million from $238.4 million for the same period in 2020. Same-unit revenue increased by approximately $19.8 million million, or 8.3% as compared to the same period in 2020. Revenue from newly acquired operations, net of divestitures, contributed $24.6 million, or 10.3%, of incremental revenue for the three months ended September 30, 2021 as compared to the same period in 2020.

Revenue for the nine months ended September 30, 2021 increased by $109.3 million, or 14.5%, to $862.1 million from $752.8 million for the same period in 2020. Same-unit revenue increased by approximately $54.5 million, or 7.3% as compared to the same period in 2020. Revenue from newly acquired operations, net of divestitures, contributed $54.8 million, or 7.3%, of incremental revenue for the nine months ended September 30, 2021 as compared to the same period in 2020. A detailed discussion of revenue by practice group is included under "Operating Practice Groups".

Income from continuing operations was $21.7 million, or $0.41 per diluted share, in the third quarter of 2021, compared to $20.1 million, or $0.36 per diluted share, in the third quarter of 2020. For the nine months ended September 30, 2021, income from continuing operations was $80.5 million, or $1.50 per diluted share, compared to $78.4 million, or $1.41 per diluted share, for the same period in 2020. Refer to “Results of Operations – Continuing Operations” for a detailed discussion of the components of income from continuing operations.

Strategic Use of Capital

Our first priority for use of capital is to make strategic acquisitions. We also have the financing flexibility and the capacity to actively repurchase shares of our common stock. We believe that repurchasing shares of our common stock can be a prudent use of our financial resources, and that investing in our stock is an attractive use of capital and an efficient means to provide value to our stockholders. We have completed five acquisitions for $66.1 million in cash and $6.9 million in our common stock. We also repurchased 2.8 million shares of our common stock at a total cost of approximately $87.9 million in the nine months ended September 30, 2021. Refer to Note 11, Business Combinations, to the accompanying condensed consolidated financial statements for further discussion on acquisitions.

23

During the first quarter of 2021, the CBIZ Board of Directors authorized the purchase of up to 5.0 million shares of our common stock under our Share Repurchase Program (the “Share Repurchase Program”), which may be suspended or discontinued at any time and expires on April 1, 2022. The shares may be purchased in the open market, in privately negotiated transactions, or pursuant to Rule 10b5-1 trading plans, which may include purchases from our employees, officers and directors, in accordance with the Securities and Exchange Commission (the “SEC”) rules. CBIZ management will determine the timing and amount of the transactions based on its evaluation of market conditions and other factors.

RESULTS OF OPERATIONS – CONTINUING OPERATIONS

Revenue

The following tables summarize total revenue for the three and nine months ended September 30, 2021 and 2020 (in thousands except percentages).

	Three Months Ended September 30,
	2021		% of Total		2020		% of Total		$ Change		% Change
Financial Services	$	187,232	66.2	%	$	155,499	65.2	%	$	31,733	20.4	%
Benefits and Insurance Services	85,797		30.3	%	73,881		31.0	%	11,916		16.1	%
National Practices	9,690		3.5	%	9,009		3.8	%	681		7.6	%
Total CBIZ	$	282,719	100.0	%	$	238,389	100.0	%	$	44,330	18.6	%

	Nine Months Ended September 30,
	2021		% of Total		2020		% of Total		$ Change		% Change
Financial Services	$	577,970	67.0	%	$	498,359	66.2	%	$	79,611	16.0	%
Benefits and Insurance Services	255,656		29.7	%	227,433		30.2	%	28,223		12.4	%
National Practices	28,471		3.3	%	26,995		3.6	%	1,476		5.5	%
Total CBIZ	$	862,097	100.0	%	$	752,787	100	%	$	109,310	14.5	%

A detailed discussion of same-unit revenue by practice group is included under “Operating Practice Groups.”

Non-qualified Deferred Compensation Plan

We sponsor a non-qualified deferred compensation plan, under which a CBIZ employee’s compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the non-qualified deferred compensation plan, which are recorded in "Corporate and Other" for segment reporting purposes, are included in “Operating expenses”, “Gross margin” and “Corporate general and administrative expenses” and are directly offset by deferred compensation gains or losses in “Other income (expense), net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. The non-qualified deferred compensation plan has no impact on “Income from continuing operations before income tax expense” or diluted earnings per share from continuing operations.

Income and expenses related to the deferred compensation plan for the three and nine months end September 30, 2021 and 2020 are as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(In thousands)
Operating (income) expenses	$	(212)	$	5,364	$	11,165	$	2,796
Corporate general and administrative expenses	(86)		672		1,260		343
Other income (expense), net	(298)		6,036		12,425		3,139

24

Excluding the impact of the above-mentioned Income and expenses related to the deferred compensation plan, the operating results for the three and nine months end September 30, 2021 and 2020 are as follows (in thousands except percentages):

	Three Months Ended September 30,
	2021								2020
	As Reported		Deferred Compensation Plan		Adjusted		% of Revenue		As Reported		Deferred Compensation Plan		Adjusted		% of Revenue
Gross margin	$	44,391	$	(212)	$	44,179	15.6	%	$	33,629	$	5,364	$	38,993	16.4	%
Operating (loss) income	31,356		(298)		31,058		11.0	%	22,290		6,036		28,326		11.9	%
Other income (expense), net	(1,133)		298		(835)		(0.3)	%	5,914		(6,036)		(122)		(0.1)	%
Income from continuing operations before income tax expense	29,207		—		29,207		10.3	%	27,156		—		27,156		11.4	%

	Nine Months Ended September 30,
	2021								2020
	As Reported		Deferred Compensation Plan		Adjusted		% of Revenue		As Reported		Deferred Compensation Plan		Adjusted		% of Revenue
Gross margin	$	162,864	$	11,165	$	174,029	20.2	%	$	139,184	$	2,796	$	141,980	18.9	%
Operating income	91,062		12,425		103,487		12.0	%	106,196		3,139		109,335		14.5	%
Other income (expense), net	12,029		(12,425)		(396)		—	%	3,450		(3,139)		311		—	%
Income from continuing operations before income tax expense	106,624		—		106,624		12.4	%	105,557		—		105,557		14.0	%

Operating Expenses

	Three Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Total Operating expenses	$	238,328		$	204,760		$	33,568	16.4	%
Operating expenses % of revenue	84.3		%	85.9		%
Operating expenses excluding deferred compensation	$	238,540		$	199,396		$	39,144	19.6	%
Operating expenses excluding deferred    compensation % of revenue	84.4		%	83.6		%

	Nine Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Total Operating expenses	$	699,233		$	613,603		$	85,630	14.0	%
Operating expenses % of revenue	81.1		%	81.5		%
Operating expenses excluding deferred compensation	$	688,068		$	610,807		$	77,261	12.6	%
Operating expenses excluding deferred    compensation % of revenue	79.8		%	81.1		%

Three months ended September 30, 2021 compared to September 30, 2020. Total operating expenses for the three months ended September 30, 2021 increased by $33.6 million, or 16.4%, to $238.3 million as compared to $204.8 million in the same period of 2020. The non-qualified deferred compensation plan decreased operating expenses by $0.2 million for the three months ended September 30, 2021, and increased operating expense by $5.4 million during the same period in 2020. Excluding the non-qualified deferred compensation expenses, which was recorded in "Corporate and Other" for segment reporting purposes, operating expenses would have been $238.5 million and $199.4 million, or 84.4% and 83.6% of revenue, for the three months ended September 30, 2021 and 2020, respectively.

25

The majority of our operating expenses relate to personnel costs, which includes (i) salaries and benefits, (ii) commissions paid to producers, (iii) incentive compensation, and (iv) stock-based compensation. Excluding the impact of deferred compensation, which was recorded in "Corporate and Other" for segment reporting purposes, operating expenses increased during the three months ended September 30, 2021 as compared to the same period in 2020, primarily driven by $29.4 million higher personnel costs, $1.8 million higher travel and entertainment costs, $1.1 million higher marketing expenses, $2.6 million higher computer and facility related costs, $1.2 higher depreciation and amortization expense, as well as $3.0 million higher other discretionary spending. Personnel costs are discussed in further detail under “Operating Practice Groups”.

Nine months ended September 30, 2021 compared to September 30, 2020. Total operating expenses for the nine months ended September 30, 2021 increased by $85.6 million, or 14.0%, to $699.2 million as compared to $613.6 million in the same period of 2020. The non-qualified deferred compensation plan added $11.2 million of expenses for the nine months ended September 30, 2021, and increased operating expenses by $2.8 million during the same period in 2020. Excluding the impact of deferred compensation, which was recorded in "Corporate and Other" for segment reporting purposes, the operating expense increase was primarily attributed to personnel costs increase of $70.5 million, $3.0 million higher computer and facility related costs, $1.7 million higher marketing expense, as well as $2.5 million higher depreciation and amortization expense. These increases in operating expense were offset by $2.3 million lower travel and entertainment costs and $2.6 million lower bad debt expense. Other discretionary spending increased approximately $4.5 million to support business activities.

Corporate General & Administrative (“G&A”) Expenses

	Three Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
G&A expenses	$	13,035		$	11,339		$	1,696	15.0	%
G&A expenses % of revenue	4.6		%	4.8		%
G&A expenses excluding deferred compensation	$	13,121		$	10,666		$	2,455	23.0	%
G&A expenses excluding deferred compensation % of revenue	4.6		%	4.5		%

	Nine Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
G&A expenses	$	41,334		$	32,988		$	8,346	25.3	%
G&A expenses % of revenue	4.8		%	4.4		%
G&A expenses excluding deferred compensation	$	40,074		$	32,645		$	7,429	22.8	%
G&A expenses excluding deferred compensation % of revenue	4.6		%	4.3		%

Three months ended September 30, 2021 compared to September 30, 2020. The increase in G&A expenses excluding deferred compensation is primarily due to higher personnel costs of $1.3 million and $1.1 million higher expense for professional services.

Nine months ended September 30, 2021 compared to September 30, 2020. The increase in G&A expenses excluding deferred compensation is primarily due to higher personnel costs of $5.0 million and $2.3 million higher expenses for professional services.

26

Legal Settlement, net

On June 24, 2021, we reached a settlement agreement with University of Pittsburgh Medical Center pertaining a lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. Under the terms of the settlement agreement, we paid a total settlement amount of $41.5 million and recorded a settlement loss of $30.5 million for the nine months ended September 30, 2021.

Other Income (Expense), Net

	Three Months Ended September 30,
	2021		2020		$ Change		% Change
	(In thousands, except percentages)
Interest expense	$	(1,016)	$	(974)	$	(42)	4.3	%
Loss on sale of operations, net	—		(74)		74		N/M
Other (expense) income, net (1)	(1,133)		5,914		(7,047)		(119.2)	%
Total other (expense) income, net	$	(2,149)	$	4,866	$	(7,015)	N/M

	Nine Months Ended September 30,
	2021		2020		$ Change		% Change
	(In thousands, except percentages)
Interest expense	$	(2,852)	$	(4,167)	$	1,315	(31.6)	%
Gain on sale of operations, net	6,385		78		6,307		N/M
Other income, net (2)	12,029		3,450		8,579		N/M
Total other income (expense), net	$	15,562	$	(639)	$	16,201	N/M

(1) Other (expense) income, net includes a net loss of $0.3 million during the three months ended September 30, 2021, compared to a net gain of $6.0 million for the same period in 2020, associated with the value of investments held in a rabbi trust related to the deferred compensation plan, which were recorded in "Corporate and Other" for segment reporting purposes. The adjustments to the investments held in a rabbi trust related to the deferred compensation plan are offset by a corresponding increase or decrease to compensation expense, which is recorded as “Operating expenses” and “G&A expenses.” The deferred compensation plan has no impact on “Income from continuing operations before income tax expense” or diluted earnings per share from continuing operations. In addition, included in Other (expense) income, net for the three months ended September 30, 2021 and 2020, is expense of $0.8 million and $0.1 million, respectively, related to net changes in the fair value of contingent consideration related to prior acquisitions.

(2) Other income, net includes a net gain of $12.4 million during the nine months ended September 30, 2021, compared to a net gain of $3.1 million for the same period in 2020, associated with the value of investments held in a rabbi trust related to the deferred compensation plan, which were recorded in "Corporate and Other" for segment reporting purposes. The adjustments to the investments held in a rabbi trust related to the deferred compensation plan are offset by a corresponding increase or decrease to compensation expense, which is recorded as “Operating expenses” and “G&A expenses.” The deferred compensation plan has no impact on “Income from continuing operations before income tax expense” or diluted earnings per share from continuing operations. In addition, included in Other income, net for the nine months ended September 30, 2021 and 2020, is expense of $1.6 million and income of $0.1 million, respectively, related to net changes in the fair value of contingent consideration related to prior acquisitions.

Interest Expense

Three and nine months ended September 30, 2021 compared with September 30, 2020. Our primary financing arrangement is the 2018 credit facility. During the three months ended September 30, 2021, our average debt balance and interest rate was $176.5 million and 1.80%, compared to $106.2 million and 2.60% for the same period of 2020. During the nine months ended September 30, 2021, our average debt balance and interest rate was $156.6 million and 1.89% compared to $170.5 million and 2.46% for the same period of 2020. The increase in interest expense for the three months ended September 30, 2021 as compared to the same period in 2020 was primarily driven by higher average debt balance, and the decrease in interest expense for the nine months ended September 30, 2021 as compared to the same period in 2020 was primarily driven by lower average debt balance

27

as well as lower interest rates. Our indebtedness is further discussed in Note 4, Debt and Financing Arrangements, to the accompanying condensed consolidated financial statements.

Gain on Sale of Operations, Net

Three and nine months ended September 30, 2021 compared with September 30, 2020. We sold a small book of business and a business unit in the Benefits and Insurance practice group during the nine months ended September 30, 2021. Total proceeds from the sales were $9.8 million. Net gain from the sales were approximately $6.4 million. During the nine months ended September 30, 2020, we sold a small book of business in the Benefits and Insurance practice group and a small accounting firm in the Financial Services practice group for a net gain of $0.1 million.

Other Income (Expense), Net

Three and nine months ended September 30, 2021 compared with September 30, 2020. For the three months ended September 30, 2021, other expense, net includes a net loss of $0.3 million associated with the non-qualified deferred compensation plan. For the same period in 2020, other income, net, includes a net gain of $6.0 million associated with the non-qualified deferred compensation plan.

For the nine months ended September 30, 2021, other income, net includes a net gain of $12.4 million associated with the non-qualified deferred compensation plan. For the same period in 2020, other income, net includes a net gain of $3.1 million associated with the non-qualified deferred compensation plan.

Income Tax Expense

	Three Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Income tax expense	$	7,512		$	7,060		$	452	6.4	%
Effective tax rate	25.7		%	26.0		%

	Nine Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Income tax expense	$	26,100		$	27,120		$	(1,020)	(3.8)	%
Effective tax rate	24.5		%	25.7		%

Three and nine months ended September 30, 2021 compared with September 30, 2020. The effective tax rate for the three months ended September 30, 2021 was 25.7%, compared to an effective tax rate of 26.0% for the comparable period in 2020. The effective tax rate for the nine months ended September 30, 2021 was 24.5%, compared to an effective tax rate of 25.7% for the same period in 2020. The decrease in the effective tax rate year over year was primarily due to a larger tax benefit recognized in the current year related to stock-based compensation.

Operating Practice Groups

We deliver our integrated services through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. A description of these groups' operating results and factors affecting their businesses is provided below.

Same-unit revenue represents total revenue adjusted to reflect comparable periods of activity for acquisitions and divestitures. Divested operations represent operations that did not meet the criteria for treatment as discontinued operations.

28

Financial Services

	Three Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Revenue
Same-unit	$	169,407		$	155,159		$	14,248	9.2	%
Acquired businesses	17,825			—			17,825
Divested operations	—			340			(340)
Total revenue	$	187,232		$	155,499		$	31,733	20.4	%
Operating expenses	156,178			129,922			26,256		20.2	%
Gross margin / Operating income	$	31,054		$	25,577		$	5,477	21.4	%
Total other income (expense), net	18			(90)			108		(120.0)	%
Income from continuing operations before income tax expenses	31,072			25,487			5,585		21.9	%
Gross margin percent	16.6		%	16.4		%

	Nine Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Revenue
Same-unit	$	539,161		$	496,081		$	43,080	8.7	%
Acquired businesses	38,809			—			38,809
Divested operations	—			2,278			(2,278)
Total revenue	$	577,970		$	498,359		$	79,611	16.0	%
Operating expenses	448,844			395,937			52,907		13.4	%
Gross margin / Operating income	$	129,126		$	102,422		$	26,704	26.1	%
Total other income, net	310			7			303		NM
Income from continuing operations before income tax expenses	129,436			102,429			27,007		26.4	%
Gross margin percent	22.3		%	20.6		%

Three months ended September 30, 2021 compared to September 30, 2020

Revenue

The Financial Services practice group revenue for the three months ended September 30, 2021 grew by 20.4% to $187.2 million from $155.5 million during the same period in 2020. Same-unit revenue grew by $14.2 million, or 9.2%, across all service lines, primarily driven by those units that provide traditional accounting and tax-related services, which increased $6.3 million, and those units that provide project-oriented advisory services, which increased by $7.1 million, as well as an increase of $0.7 million in government healthcare compliance business. The impact of acquired businesses, net of divestitures, contributed $17.5 million, or 9.3% of 2021 revenue.

We provide a range of services to affiliated CPA firms under joint referral and administrative service agreements (“ASAs”). Fees earned under the ASAs are recorded as revenue in the accompanying Condensed Consolidated Statements of Comprehensive Income and were approximately $39.7 million and $35.0 million for the three months ended September 30, 2021 and 2020, respectively.

Operating Expenses

Operating expenses increased by $26.3 million, or 20.2%, as compared to the same period last year. Personnel costs increased by $20.2 million, or 15.5%, with acquisitions contributing approximately $11.2 million to the increase, as well as $1.1 million higher travel and entertainment costs. In addition, other operating expenses, including marketing, recruiting, professional services, technology, facilities, and depreciation and amortization expenses increased by approximately $3.3 million to support the business growth. Operating expense as a

29

percentage of revenue decreased to 83.4% for the quarter ended September 30, 2021 from 83.6% of revenue for the prior year quarter.

Nine months ended September 30, 2021 compared to September 30, 2020

Revenue

Revenue for the nine months ended September 30, 2021 grew by 16.0% to $578.0 million from $498.4 million during the same period in 2020. Same-unit revenue grew by $43.1 million, or 8.7%, across all service lines, primarily driven by those units that provide traditional accounting and tax-related services, which increased $24.5 million, and those units that provide project-oriented advisory services, which increased by $14.1 million, as well as an increase of $4.0 million in government healthcare compliance business. The impact of acquired businesses, net of divestitures, contributed $36.5 million, or 6.3% of 2021 revenue.

Fees earned under the ASAs, as described above, were approximately $139.7 million and $127.4 million for the nine months ended September 30, 2021 and 2020, respectively.

Operating Expenses

Operating expenses increased by $52.9 million, or 13.4%, as compared to the same period last year. Personnel costs increased by $51.2 million, or 12.9%, with acquisitions contributing approximately $24.3 million to the increase. In addition, other operating expenses, including marketing, recruiting, professional services, technology, facilities, and depreciation and amortization expenses increased by approximately $4.3 million to support the business growth. The increase in operating expenses was offset by $0.9 million lower travel and entertainment spending and $2.7 million lower bad debt expense. In the first half of 2020, due to the COVID-19 pandemic, we recorded bad debt expense of $2.2 million, which did not recur in 2021. Operating expense as a percentage of revenue decreased to 77.7% during the nine months ended September 30, 2021 from 79.4% of revenue during the same period in 2020.

Benefits and Insurance Services

	Three Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Revenue
Same-unit	$	78,038		$	73,201		$	4,837	6.6	%
Acquired businesses	7,759			—			7,759
Divested operations	—			680			(680)
Total revenue	$	85,797		$	73,881		$	11,916	16.1	%
Operating expenses	69,039			62,013			7,026		11.3	%
Gross margin / Operating income	$	16,758		$	11,868		$	4,890	41.2	%
Total other expense, net	(9)			(44)			35		(79.5)	%
Income from continuing operations before income tax expenses	16,749			11,824			4,925		41.7	%
Gross margin percent	19.5		%	16.1		%

30

	Nine Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Revenue
Same-unit	$	236,287		$	226,311		$	9,976	4.4	%
Acquired businesses	19,369			—			19,369
Divested operations	—			1,122			(1,122)
Total revenue	$	255,656		$	227,433		$	28,223	12.4	%
Operating expenses	203,748			188,519			15,229		8.1	%
Gross margin	$	51,908		$	38,914		$	12,994	33.4	%
Total other income, net	7,248			263			6,985		NM
Income from continuing operations before income tax expenses	59,156			39,177			19,979		51.0	%
Gross margin percent	20.3		%	17.1		%

Three months ended September 30, 2021 compared to September 30, 2020

Revenue

The Benefits and Insurance Services practice group revenue increased by $11.9 million, or 16.1%, to $85.8 million during the three months ended September 30, 2021 compared to $73.9 million for the same period in 2020. The increase was primarily driven by the property and casualty and retirement benefit services lines as well as growth in our other project based services. Acquired businesses, net of divestitures, contributed $7.1 million in incremental revenue for the three months ended September 30, 2021. Same-unit revenue increased by $4.8 million, or 6.6% when compared to the same period in 2020.

Operating Expenses

Operating expenses increased by $7.0 million, or 11.3%, when compared to the same period last year. Personnel costs increased by $5.1 million, or 8.3%, primarily related to $3.6 million contributed by acquired businesses. In addition, other operating expenses, including marketing, recruiting, professional services, technology, depreciation and amortization expenses, and other direct costs increased by approximately $1.1 million to support increased business activities. Travel and entertainment cost increased by $0.4 million. Operating expense as a percentage of revenue decreased to 80.5% for the quarter ended September 30, 2021 from 83.9% of revenue for the same period in 2020.

Nine months ended September 30, 2021 compared to September 30, 2020

Revenue

The Benefits and Insurance Services practice group revenue increased by $28.2 million, or 12.4%, to $255.7 million during the nine months ended September 30, 2021 compared to $227.4 million for the same period in 2020, primarily driven by acquired businesses, net of divestitures, which contributed $18.2 million in incremental revenue. Same-unit revenue increased by $10.0 million, or 4.4% when compared to the same period in 2020, primarily driven by growth in property and casualty, employee benefits, retirement benefit services, and human capital management service lines as well as other project based services.

Operating Expenses

Operating expenses increased by $15.2 million, or 8.1%, when compared to the same period last year. Personnel cost increased by $12.3 million, or 6.5%, primarily related to $10.2 million contributed by acqauired business. In addition, other operating expenses, including marketing, recruiting, professional services, technology, depreciation and amortization expenses, and other direct costs increased by approximately $3.6 million to support increased business activities. The increase in operating expense was offset by $0.6 million lower travel and entertainment spending. Operating expense as a percentage of revenue decreased to 79.7% during the nine months ended September 30, 2021 from 82.9% of revenue for the same period in 2020.

Total Other Income, Net

31

We sold a business unit during the nine months ended September 30, 2021 for total proceeds of $9.8 million. Net gain from the sale was approximately $6.4 million. We also sold a small book of business during the nine months ended September 30, 2021, of which we recorded a gain of $0.7 million.

National Practices

	Three Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Same-unit revenue	$	9,690		$	9,009		$	681	7.6	%
Operating expenses	8,514			8,070			444		5.5	%
Gross margin / Operating Income	$	1,176		$	939		$	237	25.2	%
Total other income, net	1			—			1		NM
Income from continuing operations before income tax expenses	1,177			939			238		25.3	%
Gross margin percent	12.1		%	10.4		%

	Nine Months Ended September 30,
	2021			2020			$ Change		% Change
	(In thousands, except percentages)
Same-unit revenue	$	28,471		$	26,995		$	1,476	5.5	%
Operating expenses	25,542			24,343			1,199		4.9	%
Gross margin / Operating Income	$	2,929		$	2,652		$	277	10.4	%
Total other income, net	1			1			—		—	%
Income from continuing operations before income tax expenses	2,930			2,653			277		10.4	%
Gross margin percent	10.3		%	9.8		%

Three and nine months ended September 30, 2021 compared with September 30, 2020

Revenue and Operating Expenses

The National Practices group is primarily driven by a cost-plus contract with a single client, which has existed since 1999. The cost-plus contract is a five-year contract with the most recent renewal through December 31, 2023. Revenues from this single client accounted for approximately 75% of the National Practice group’s revenue. During the three and nine months ended September 30, 2021, revenue increased by $0.7 million, or 7.6%, and $1.5 million, or 5.5%, respectively, while operating expenses increased by $0.4 million, or 5.5%, and $1.2 million, or 4.9%, respectively.

32

Corporate and Other

Corporate and Other are operating expenses that are not directly allocated to the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in our non-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs and other various expenses.

	Three Months Ended September 30,
	2021		2020		$ Change	% Change
	(In thousands, except percentages)
Operating expenses	$	4,597	$	4,755	(158)	(3.3)	%
Corporate general and administrative expenses	13,035		11,339		1,696	15.0	%
Operating loss	(17,632)		(16,094)		(1,538)	9.6	%
Total other (expense) income, net	(2,159)		5,000		(7,159)	(143.2)	%
Loss from continuing operations before income tax expenses	(19,791)		(11,094)		(8,697)	78.4	%

	Nine Months Ended September 30,
	2021		2020		$ Change	% Change
	(In thousands, except percentages)
Operating expenses	$	21,099	$	4,804	16,295	339.2	%
Corporate general and administrative expenses	41,334		32,988		8,346	25.3	%
Legal settlement, net	30,468		—		30,468	NM
Operating loss	(92,901)		(37,792)		(55,109)	145.8	%
Total other income (expense), net	8,003		(910)		8,913	(979.5)	%
Loss from continuing operations before income tax expenses	(84,898)		(38,702)		(46,196)	119.4	%

Three months ended September 30, 2021 compared to September 30, 2020

Total operating expenses decreased by $0.2 million, or 3.3%, during the three months ended September 30, 2021, as compared to the same period in 2020. The non-qualified deferred compensation plan decreased operating expenses by $0.2 million for the three months ended September 30, 2021 and increased operating expenses by $5.4 million during the same period in 2020. Excluding the non-qualified deferred compensation expenses, operating expense increased by approximately $5.4 million, primarily driven by $4.3 million higher personnel costs and $1.0 million higher computer and technology costs to support business growth.

Total Corporate general and administrative expenses increased by $1.7 million, or 15.0%, during the three months ended September 30, 2021, as compared to the same period in 2020. The non-qualified deferred compensation plan increased G&A expenses by $1.3 million for the three months ended September 30, 2021, and by $0.3 million during the same period in 2020. Excluding the non-qualified deferred compensation expenses, G&A expense increased by approximately $7.4 million, primarily driven by higher personnel costs of $5.0 million and $2.1 million higher expense for professional services.

Total other (expense) income, net increased by $7.2 million, or 143.2%, during the three months ended September 30, 2021, as compared to the same period in 2020. Total other (expense) income, net for the three months ended September 30, 2021 includes a net loss of $0.3 million associated with the non-qualified deferred compensation plan. For the same period in 2020, other income, net includes a net gain of $6.0 million associated with the non-qualified deferred compensation plan. Excluding the impact of the non-qualified deferred compensation plan, total other (expense) income, net increased by $0.8 million, primarily due to higher fair value adjustment related to the contingent purchase price considerations.

33

Nine months ended September 30, 2021 compared to September 30, 2020

Total operating expenses increased by $16.3 million, or 339.2%, during the nine months ended September 30, 2021, as compared to the same period in 2020. The non-qualified deferred compensation plan increased operating expenses by $11.2 million for the nine months ended September 30, 2021, and by $2.8 million during the same period in 2020. Excluding the non-qualified deferred compensation expenses, operating expense increased by approximately $7.9 million, primarily driven by $6.7 million higher personnel costs and $1.1 million higher marketing costs to support business growth.

Total G&A expenses increased by $8.3 million, or 25.3%, during the nine months ended September 30, 2021, as compared to the same period in 2020. The non-qualified deferred compensation plan decreased G&A expenses by $0.1 million for the nine months ended September 30, 2021, and increased G&A expense by $0.7 million during the same period in 2020. Excluding the non-qualified deferred compensation expenses, G&A expense increased by approximately $2.5 million, primarily driven by higher personnel costs of $1.3 million and $1.1 million higher expense for professional services.

On June 24, 2021, we reached a settlement agreement with University of Pittsburgh Medical Center pertaining a lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. Under the terms of the settlement agreement, we paid a total settlement amount of $41.5 million and recorded a settlement loss of $30.5 million for the nine months ended September 30, 2021.

Total other income (expense), net increased by $8.9 million, or 979.5%, during the nine months ended September 30, 2021, as compared to the same period in 2020. Total other income (expense), net for the nine months ended September 30, 2021 includes a net gain of $12.4 million associated with the non-qualified deferred compensation plan. For the same period in 2020, other income, net includes a net gain of $3.1 million associated with the non-qualified deferred compensation plan. Excluding the impact of the non-qualified deferred compensation plan, total other income (expense), net decreased by $0.4 million, primarily due to $1.7 million higher fair value adjustment related to the contingent purchase price considerations, offset by $1.3 million lower interest expense due to lower average outstanding balance and interest rates during 2021 as compared to 2020.

LIQUIDITY

Our principal sources of liquidity are cash generated from operating activities and financing activities. Our cash flows from operating activities are driven primarily by our operating results and changes in our working capital requirements while our cash flows from financing activities are dependent upon our ability to access credit or other capital. We historically maintain low cash levels and apply any available cash to pay down the outstanding debt balance.

We historically experience a use of cash to fund working capital requirements during the first quarter of each fiscal year. This is primarily due to the seasonal accounting and tax services period under the Financial Services practice group, as well as payment of accrued employees' incentives programs. Upon completion of the seasonal accounting and tax services period, cash provided by operations during the remaining three quarters of the fiscal year substantially exceeds the use of cash in the first quarter of the fiscal year.

Accounts receivable balances increase in response to the first nine months revenue generated by the Financial Services practice group. A significant amount of this revenue is billed and collected in subsequent quarters. Days sales outstanding (“DSO”) from continuing operations represent accounts receivable and unbilled revenue (net of realization adjustments) at the end of the period, divided by trailing twelve months daily revenue. We provide DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of our ability to collect on receivables in a timely manner. DSO was 88 days and 87 days at September 30, 2021 and 2020, respectively. DSO at December 31, 2020 was 72 days.

The following table presents selected cash flow information (in thousands). For additional details, refer to the accompanying Condensed Consolidated Statements of Cash Flows.

34

	Nine Months Ended September 30,
	2021		2020
Net cash provided by operating activities	$	80,946	$	81,796
Net cash used in investing activities	(70,728)		(9,491)
Net cash provided by (used in) financing activities	1,678		(94,058)
Net increase (decrease) in cash, cash equivalents and restricted cash	$	11,896	$	(21,753)

Operating Activities - Cash provided by operating activities was $80.9 million during the nine months ended September 30, 2021, primarily due to net income of $80.5 million and certain non-cash items, such as depreciation and amortization expense of $19.9 million, deferred income tax of $7.1 million, and stock-based compensation expense of $8.4 million. The cash inflow was offset by working capital use of $26.3 million. Cash provided by operating activities was $81.8 million during the nine months ended September 30, 2020, primarily due to $78.4 million of net income and certain non-cash items, such as depreciation and amortization expense, totaling $24.0 million. This cash inflow was offset by $20.6 million cash used to fund working capital needs.

Investing Activities - Cash used in investing activities during the nine months ended September 30, 2021 was $70.7 million and consisted primarily of $66.2 million used for business acquisitions, $6.5 million in capital expenditures, and $8.0 million net activity related to funds held for clients. The use of cash was offset by other investing activities, such as proceeds from sales of divested operations of $9.8 million. Cash used in investing activities during the nine months ended September 30, 2020 consisted primarily of $33.8 million net cash used for acquisitions, $9.5 million capital expenditures, offset by proceeds from sales and maturities of client fund investments of $33.0 million.

The balances in funds held for clients and client fund obligations can fluctuate with the timing of cash receipts and the related cash payments. The nature of these accounts is further described in Note 1, Organization and Summary of Significant Accounting Policies, to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020.

Financing Activities - Cash provided by financing activities during the nine months ended September 30, 2021 was $1.7 million and primarily consisted of $82.2 million in net proceeds from the credit facility, $8.4 million net increase in client fund obligations and $7.1 million proceeds from exercise of stock options, partially offset by $88.0 million in share repurchases and $7.9 million in contingent consideration payments related to prior acquisitions. Cash used in financing activities during the nine months ended September 30, 2020 primarily consisted of $57.5 million net decrease in client fund obligations, $34.1 million used to repurchase our common stock, as well as $11.2 million in contingent consideration payments related to prior acquisitions, partially offset by $4.5 million in net borrowings under our 2018 credit facility.

CAPITAL RESOURCES

Credit Facility - At September 30, 2021, we had $190.2 million outstanding under the 2018 credit facility as well as $3.4 million letters of credit. Available funds under the 2018 credit facility, based on the terms of the commitment, were approximately $201.6 million at September 30, 2021. The weighted average interest rate under the 2018 credit facility was 1.89% in the first nine months of 2021, compared to 2.46% for the same period in 2020. The 2018 credit facility allows for the allocation of funds for future strategic initiatives, including acquisitions and the repurchase of our common stock, subject to the terms and conditions of the 2018 credit facility.

Debt Covenant Compliance - We are required to meet certain financial covenants with respect to (i) total leverage ratio and (ii) a minimum fixed charge coverage ratio. We are in compliance with our financial covenants as of September 30, 2021. Our ability to service our debt and to fund future strategic initiatives will depend upon our ability to generate cash in the future. For further discussion regarding our 2018 credit facility and debt, refer to Note 4, Debt and Financing Arrangements, to the accompanying condensed consolidated financial statements.

Use of Capital - Our first priority for use of capital is to make strategic acquisitions. We also have the financing flexibility and the capacity to actively repurchase shares of our common stock. We believe that repurchasing shares

35

of our common stock can be a prudent use of our financial resources, and that investing in our stock is an attractive use of capital and an efficient means to provide value to our stockholders. We have completed five acquisitions for $66.1 million in cash and $6.9 million in our common stock. We also repurchased 2.8 million shares of our common stock at a total cost of approximately $87.9 million during the nine months ended September 30, 2021. Refer to Note 11, Business Combinations, to the accompanying condensed consolidated financial statements for further discussion on acquisitions.

OFF-BALANCE SHEET ARRANGEMENTS

We maintain administrative service agreements with independent CPA firms (as described more fully under “Business – Financial Services” and in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020), which qualify as variable interest entities. The accompanying condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations, or cash flows of CBIZ.

We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $3.4 million and $1.7 million at September 30, 2021 and December 31, 2020, respectively. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.3 million and $2.2 million at September 30, 2021 and December 31, 2020, respectively.

We have various agreements under which we may be obligated to indemnify the other party with respect to certain matters. Generally, these indemnification clauses are included in contracts arising in the normal course of business under which we customarily agree to hold the other party harmless against losses arising from a breach of representations, warranties, covenants or agreements, related to matters such as title to assets sold and certain tax matters. Payment by us under such indemnification clauses is generally conditioned upon the other party making a claim. Such claims are typically subject to challenge by us and to dispute resolution procedures specified in the particular contract. Further, our obligations under these agreements may be limited in terms of time and/or amount and, in some instances, we may have recourse against third parties for certain payments made by us. It is not possible to predict the maximum potential amount of future payments under these indemnification agreements due to the conditional nature of our obligations and the unique facts of each particular agreement. Historically, we have not made any payments under these agreements that have been material individually or in the aggregate. As of September 30, 2021, we are not aware of any material obligations arising under indemnification agreements that would require payment.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The SEC defines critical accounting policies as those that are most important to the portrayal of a company’s financial condition and results and that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

Our discussion and analysis of our results of operations, financial condition and liquidity are based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the amounts of assets and liabilities, revenues and expenses and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements. As more information becomes known, these estimates and assumptions could change, which would have an impact on actual results that may differ materially from these estimates and judgments under different assumptions. We have not made any changes to our critical accounting policies and estimates as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

NEW ACCOUNTING PRONOUNCEMENTS

Refer to Note 2, New Accounting Pronouncements, to the accompanying condensed consolidated financial statements for a discussion of recently issued accounting pronouncements.

FORWARD-LOOKING STATEMENTS

36

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact included in this Quarterly Report, including without limitation, "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding our financial position, business strategy and plans and objectives for future performance are forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are commonly identified by the use of such terms and phrases as "intends", "believes", "estimates", "expects", "projects", "anticipates", "foreseeable future", "seeks", and words or phrases of similar import in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated services, sales efforts, expenses, and financial results. From time to time, we also may provide oral or written forward-looking statements in other materials we release to the public. Any or all of our forward-looking statements in this Quarterly Report on Form 10-Q and in any other public statements that we make, are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the impact of COVID-19 on the Company’s business and operations and those of our clients; the Company’s ability to adequately manage and sustain its growth; the Company’s dependence on the current trend of outsourcing business services; the Company’s dependence on the services of its CEO and other key employees; competitive pricing pressures; general business and economic conditions; and changes in governmental regulation and tax laws affecting the Company’s insurance business or its business service operations. Such forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Should one or more of these risks materialize, or should the underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected.

Consequently, no forward-looking statement can be guaranteed. A more detailed description of risk factors may be found in “Item 1A, Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2020. Except as required by the federal securities laws, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our filings with the SEC, such as quarterly, periodic and annual reports.

37

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our floating rate debt under our 2018 credit facility exposes us to interest rate risk. Interest rate risk results when the maturity or repricing intervals of interest-earning assets and interest-bearing liabilities are different. A change in the Federal Funds Rate, or the reference rate set by Bank of America, N.A., would affect the rate at which we could borrow funds under the credit facility. The balance outstanding under our credit facility at September 30, 2021 was $190.2 million, of which $105.2 million is subject to rate risk. If market rates were to increase or decrease 100 basis points from the levels at September 30, 2021, interest expense would increase or decrease approximately $1.1 million annually.

We do not engage in trading market risk sensitive instruments. We periodically use interest rate swaps to manage interest rate risk exposure. The interest rate swaps effectively modify our exposure to interest rate risk, primarily through converting portions of our floating rate debt under the credit facility to a fixed rate basis. These agreements involve the receipt or payment of floating rate amounts in exchange for fixed rate interest payments over the life of the agreements without an exchange of the underlying principal amounts.

At September 30, 2021, we had three interest rate swaps with notional values, fixed rates of interest and expiration dates of (i) $20.0 million – 1.770% - May 2022, (ii) $15.0 million – 2.640% - June 2023, and (iii) $50.0 million – 0.885% - April 2025, respectively. Management will continue to evaluate the potential use of interest rate swaps as we deem appropriate under certain operating and market conditions. We do not enter into derivative instruments for trading or speculative purposes.

In connection with the services provided by our payroll operations, funds collected from our clients’ accounts in advance are segregated and may be invested in short-term investments, such as corporate and municipal bonds. In accordance with our investment policy, all investments carry an investment grade rating at the time of the initial acquisition, and are classified as available-for-sale securities. At each respective balance sheet date, these investments are adjusted to fair value with fair value adjustments being recorded to other comprehensive income or loss and reflected in the accompanying Condensed Consolidated Statements of Comprehensive Income for the respective period. If an investment is deemed to be other-than-temporarily impaired due to credit loss, then the adjustment is recorded to “Other income (expense), net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. Refer to Note 6, Financial Instruments, and Note 7, Fair Value Measurements, to the accompanying condensed consolidated financial statements for further discussion regarding these investments and the related fair value assessments.

ITEM 4. CONTROLS AND PROCEDURES

(a) Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management has evaluated the effectiveness of our disclosure controls and procedures (“Disclosure Controls”) as of the end of the period covered by this report. This evaluation (“Controls Evaluation”) was done with the participation of the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”). Disclosure Controls are controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure Controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to management, including the CEO and CFO as appropriate, to allow timely decisions regarding required disclosure.

Limitations on the Effectiveness of Controls

Management, including our CEO and CFO, does not expect that our Disclosure Controls or our internal control over financial reporting will prevent all errors and all fraud. Although our Disclosure Controls are designed to provide reasonable assurance of achieving their objective, a control system, no matter how well conceived and operated, can provide only reasonable, but not absolute, assurance that the objectives of a control system are met. Further, any control system reflects limitations on resources, and the benefits of a control system must be considered relative to its costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within CBIZ have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can

38

occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of a control. A design of a control system is also based upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

Conclusions

Our Disclosure Controls are designed to provide reasonable assurance of achieving their objectives and, based upon the Controls Evaluation, our CEO and CFO have concluded that as of the end of the period covered by this report, CBIZ’s Disclosure Controls were effective at that reasonable assurance level.

(b) Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting during the quarter ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

39

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Information regarding certain legal proceedings in which we are involved is incorporated by reference from Note 5, Commitments and Contingencies, to the accompanying condensed consolidated financial statements.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC. These risks could materially and adversely affect the business, financial condition and results of operations of CBIZ.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) Recent sales of unregistered securities

During the nine months ended September 30, 2021, approximately 66 thousand shares of our common stock were issued as payment for contingent consideration for previous acquisitions. The foregoing shares were issued in transactions not involving a public offering in reliance on the exemption from registration afforded by Section 4(a)(2) of the Securities Act. The persons to whom the shares were issued had access to full information about the Company and represented that they acquired the shares for their own account and not for the purpose of distribution. The certificates for the shares contain a restrictive legend advising that the shares may not be offered for sale, sold, or otherwise transferred without having first been registered under the Securities Act or pursuant to an exemption from the Securities Act.

(b) Issuer purchases of equity securities

On February 11, 2021, our Board of Directors authorized the continuation of the Share Repurchase Program, which has been renewed annually for the past seventeen years. It was effective beginning April 1, 2021, and the amount of shares to be purchased was reset to 5 million, and expires one year from the effective date. The Share Repurchase Program allows us to purchase shares of our common stock (i) in the open market, (ii) in privately negotiated transactions, and (iii) under Rule 10b5-1 trading plans. Privately negotiated transactions may include purchases from our employees, Officers and Directors, in accordance with SEC rules. Rule 10b5-1 trading plans allow for repurchases during periods when we would not normally be active in the trading market due to regulatory restrictions. The Share Repurchase Program does not obligate us to acquire any specific number of shares and may be suspended at any time.

Shares repurchased under the Share Repurchase Program during the three months ended September 30, 2021 (reported on a trade-date basis) are summarized in the table below (in thousands, except per share data). Average price paid per share includes fees and commissions.

	Issuer Purchases of Equity Securities
Third Quarter Purchases	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plan	Maximum Number of Shares That May Yet Be Purchased Under the Plan
July 1 – July 31, 2021	—	$	—	—	4,036
August 1 – August 31, 2021	332	$	33.01	332	3,704
September 1 –September 30, 2021	318	$	32.97	318	3,386
Third quarter purchases	650	$	32.99	650

According to the terms of our 2018 credit facility, we are not permitted to declare or make any dividend payments, other than dividend payments made by one of our wholly owned subsidiaries to the parent company. Refer to Note 9, Debt and Financing Arrangements, to the consolidated financial statements in the Annual Report on Form 10-K for the year ended December 31, 2020 for a description of working capital restrictions and limitations on the payment of dividends.

40

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

41

Item 6. Exhibits

10.1 *	Third Amendment to Loan Agreement by and among CBIZ Benefit and Insurance, Inc. and The Huntington National Bank
31.1 *	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2 *	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 **	Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 **	Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document*
101.SCH	Inline XBRL Taxonomy Extension Schema Document*
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Exhibit 101 attachments)

*    Indicates documents filed herewith.

**    Indicates document furnished herewith.

42

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			CBIZ, Inc.
			(Registrant)
Date:	October 29, 2021	By:	/s/ Ware H. Grove
			Ware H. Grove
			Chief Financial Officer
			Duly Authorized Officer and Principal Financial Officer

EX-10.1

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF CBIZ, INC.

I, Jerome P. Grisko, Jr., President and Chief Executive Officer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of CBIZ, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 29, 2021	/s/ JEROME P. GRISKO, JR.
	Jerome P. Grisko, Jr.
	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF CBIZ, INC.

I, Ware H. Grove, Chief Financial Officer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of CBIZ, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 29, 2021	/s/ WARE H. GROVE
	Ware H. Grove
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF CBIZ, INC.

This certification is provided pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, and accompanies the Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the “Form 10-Q”) of CBIZ, Inc. (the “Issuer”) filed with the Securities and Exchange Commission on the date hereof.

I, Jerome P. Grisko, Jr., the President and Chief Executive Officer of the Issuer, certify that to the best of my knowledge:

(i)the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(ii)the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Date: October 29, 2021	/s/ JEROME P. GRISKO, JR.
	Jerome P. Grisko, Jr.
	President and Chief Executive Officer

Subscribed and sworn to before me on this 29th day of October, 2021.

/s/ MICHAEL W. GLEESPEN
Name:	Michael W. Gleespen
Title:	Notary Public & Attorney-At-Law

Registered in Franklin County, Ohio

No Expiration Date

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF CBIZ, INC.

This certification is provided pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, and accompanies the Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the “Form 10-Q”) of CBIZ, Inc. (the “Issuer”) filed with the Securities and Exchange Commission on the date hereof.

I, Ware H. Grove, the Chief Financial Officer of the Issuer, certify that to the best of my knowledge:

(i)the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(ii)the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Date: October 29, 2021	/s/ WARE H. GROVE
	Ware H. Grove
	Chief Financial Officer

Subscribed and sworn to before me on this 29th day of October, 2021.

/s/ MICHAEL W. GLEESPEN
Name:	Michael W. Gleespen
Title:	Notary Public & Attorney-At-Law

Registered in Franklin County, Ohio

No Expiration Date

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Oct. 21, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	1-32961
Entity Registrant Name	CBIZ, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-2769024
Entity Address, Address Line One	6050 Oak Tree Boulevard
Entity Address, Address Line Two	South
Entity Address, Address Line Three	Suite 500
Entity Address, City or Town	Cleveland
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44131
City Area Code	216
Local Phone Number	447-9000
Title of 12(b) Security	Common Stock, $0.01 Par Value
Trading Symbol	CBZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		52,092,215
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000944148
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 2,749	$ 4,652
Restricted cash	37,320	23,951
Accounts receivable, net	293,890	216,175
Other current assets	25,694	24,213
Current assets before funds held for clients	359,653	268,991
Funds held for clients	175,451	167,440
Total current assets	535,104	436,431
Non-current assets:
Property and equipment, net	42,531	41,346
Goodwill and other intangible assets, net	843,246	756,750
Assets of deferred compensation plan	136,059	127,332
Operating lease right-of-use assets, net	152,131	147,843
Other non-current assets	3,697	4,052
Total non-current assets	1,177,664	1,077,323
Total assets	1,712,768	1,513,754
Current liabilities:
Accounts payable	75,607	64,119
Income taxes payable	7,971	2,788
Accrued personnel costs	96,924	79,978
Contingent purchase price liabilities	32,747	20,288
Operating lease liabilities	31,449	30,483
Other current liabilities	21,769	13,629
Current liabilities before client fund obligations	266,467	211,285
Client fund obligations	175,364	166,989
Total current liabilities	441,831	378,274
Non-current liabilities:
Bank debt	190,200	108,000
Debt issuance costs	(538)	(808)
Total long-term debt	189,662	107,192
Income taxes payable	1,836	1,775
Deferred income taxes, net	16,226	8,752
Deferred compensation plan obligations	136,059	127,332
Contingent purchase price liabilities	51,881	34,103
Operating lease liabilities	145,229	142,020
Other non-current liabilities	9,397	11,686
Total non-current liabilities	550,290	432,860
Total liabilities	992,121	811,134
STOCKHOLDERS' EQUITY
Common stock	1,351	1,341
Additional paid in capital	765,329	740,970
Retained earnings	638,382	557,875
Treasury stock	(683,217)	(595,297)
Accumulated other comprehensive loss	(1,198)	(2,269)
Total stockholders’ equity	720,647	702,620
Total liabilities and stockholders’ equity	$ 1,712,768	$ 1,513,754

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Revenue	$ 282,719	$ 238,389	$ 862,097	$ 752,787
Operating expenses	238,328	204,760	699,233	613,603
Gross margin	44,391	33,629	162,864	139,184
Corporate general and administrative expenses	13,035	11,339	41,334	32,988
Legal settlement, net	0	0	30,468	0
Operating income	31,356	22,290	91,062	106,196
Other income (expense):
Interest expense	(1,016)	(974)	(2,852)	(4,167)
Gain (loss) on sale of operations, net	0	(74)	6,385	78
Other (expense) income, net	(1,133)	5,914	12,029	3,450
Total other (expense) income, net	(2,149)	4,866	15,562	(639)
Income from continuing operations before income tax    expense	29,207	27,156	106,624	105,557
Income tax expense	7,512	7,060	26,100	27,120
Income from continuing operations	21,695	20,096	80,524	78,437
Loss from discontinued operations, net of tax	(4)	(19)	(17)	(44)
Net income	$ 21,691	$ 20,077	$ 80,507	$ 78,393
Basic:
Continuing operations (in dollars per share)	$ 0.41	$ 0.37	$ 1.52	$ 1.44
Discontinued operations (in dollars per share)	0	0	0	0
Net income (in dollars per share)	0.41	0.37	1.52	1.44
Diluted:
Continuing operations (in dollars per share)	0.41	0.36	1.50	1.41
Discontinued operations (in dollars per share)	0	0	0	0
Net income (in dollars per share)	$ 0.41	$ 0.36	$ 1.50	$ 1.41
Basic weighted average shares outstanding (in shares)	52,425	54,403	52,885	54,372
Diluted weighted average shares outstanding (in shares)	53,226	55,360	53,796	55,473
Comprehensive income:
Net income	$ 21,691	$ 20,077	$ 80,507	$ 78,393
Other comprehensive income (loss), net of tax	159	(186)	1,071	(1,815)
Comprehensive income	$ 21,850	$ 19,891	$ 81,578	$ 76,578

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019		133,056	77,637
Beginning balance at Dec. 31, 2019	$ 659,238	$ 1,331	$ (535,693)	$ 714,704	$ 479,576	$ (680)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	78,393				78,393
Other comprehensive income (loss)	(1,815)					(1,815)
Share repurchases (in shares)			1,312
Share repurchases	(32,771)		$ (32,771)
Indirect repurchase of shares for minimum tax withholding (in shares)			97
Indirect repurchase of shares for minimum tax withholding	(2,040)		$ (2,040)
Restricted stock units and awards (in shares)		40
Stock options exercised (in shares)		442
Stock options exercised	4,719	$ 5		4,714
Stock-based compensation	6,765			6,765
Business acquisitions (in shares)		221
Business acquisitions	5,515	$ 2		5,513
Ending balance (in shares) at Sep. 30, 2020		133,759	79,046
Ending balance at Sep. 30, 2020	718,004	$ 1,338	$ (570,504)	731,696	557,969	(2,495)
Beginning balance (in shares) at Jun. 30, 2020		133,536	78,881
Beginning balance at Jun. 30, 2020	695,220	$ 1,335	$ (566,762)	725,064	537,892	(2,309)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,077				20,077
Other comprehensive income (loss)	(186)					(186)
Share repurchases (in shares)			165
Share repurchases	(3,742)		$ (3,742)
Stock options exercised (in shares)		115
Stock options exercised	1,492	$ 2		1,490
Stock-based compensation	2,485			2,485
Business acquisitions (in shares)		108
Business acquisitions	2,658	$ 1		2,657
Ending balance (in shares) at Sep. 30, 2020		133,759	79,046
Ending balance at Sep. 30, 2020	718,004	$ 1,338	$ (570,504)	731,696	557,969	(2,495)
Beginning balance (in shares) at Dec. 31, 2020		134,144	80,045
Beginning balance at Dec. 31, 2020	702,620	$ 1,341	$ (595,297)	740,970	557,875	(2,269)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	80,507				80,507
Other comprehensive income (loss)	1,071					1,071
Share repurchases (in shares)			2,686
Share repurchases	(84,883)		$ (84,883)
Indirect repurchase of shares for minimum tax withholding (in shares)			92
Indirect repurchase of shares for minimum tax withholding	(3,037)		$ (3,037)
Restricted stock units and awards (in shares)		80
Restricted stock units and awards	$ 0	$ 1		(1)
Stock options exercised (in shares)	635	635
Stock options exercised	$ 7,143	$ 6		7,137
Stock-based compensation	8,359			8,359
Business acquisitions (in shares)		274
Business acquisitions	8,867	$ 3		8,864
Ending balance (in shares) at Sep. 30, 2021		135,133	82,823
Ending balance at Sep. 30, 2021	720,647	$ 1,351	$ (683,217)	765,329	638,382	(1,198)
Beginning balance (in shares) at Jun. 30, 2021		134,892	82,173
Beginning balance at Jun. 30, 2021	712,332	$ 1,349	$ (661,772)	757,421	616,691	(1,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	21,691				21,691
Other comprehensive income (loss)	159					159
Share repurchases (in shares)			650
Share repurchases	(21,445)		$ (21,445)
Stock options exercised (in shares)		142
Stock options exercised	1,695	$ 1		1,694
Stock-based compensation	2,905			2,905
Business acquisitions (in shares)		99
Business acquisitions	3,310	$ 1		3,309
Ending balance (in shares) at Sep. 30, 2021		135,133	82,823
Ending balance at Sep. 30, 2021	$ 720,647	$ 1,351	$ (683,217)	$ 765,329	$ 638,382	$ (1,198)

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income	$ 80,507	$ 78,393
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	19,921	17,277
Gain (loss) on sale of operations, net	(6,385)	(78)
Bad debt expense, net of recoveries	562	3,166
Adjustment to contingent earnout liability	1,599	(80)
Stock-based compensation expense	8,359	6,765
Excess tax benefits from share based payment arrangements	(4,114)	(1,674)
Deferred income taxes	7,141	(1,809)
Other, net	(373)	388
Changes in assets and liabilities, net of acquisitions and divestitures:
Accounts receivable, net	(66,017)	(27,913)
Other assets	53	1,823
Accounts payable	12,126	(18,404)
Income taxes payable	9,359	12,048
Accrued personnel costs	15,329	(4,862)
Other liabilities	2,897	16,822
Operating cash flows provided by continuing operations	80,964	81,862
Operating cash flows used in discontinued operations	(18)	(66)
Net cash provided by operating activities	80,946	81,796
Cash flows from investing activities:
Business acquisitions and purchases of client lists, net of cash acquired	(66,155)	(33,782)
Purchases of client fund investments	(13,050)	(3,447)
Proceeds from the sales and maturities of client fund investments	10,800	32,967
Proceeds from sales of divested operations	9,785	651
Change in funds held for clients	(5,708)	3,250
Additions to property and equipment	(6,451)	(9,486)
Other, net	51	356
Net cash used in investing activities	(70,728)	(9,491)
Cash flows from financing activities:
Proceeds from bank debt	680,400	550,454
Payment of bank debt	(598,200)	(545,954)
Payment for acquisition of treasury stock	(84,950)	(32,083)
Indirect repurchase of shares for minimum tax withholding	(3,037)	(2,040)
Changes in client funds obligations	8,375	(57,517)
Proceeds from exercise of stock options	7,143	4,719
Payment of contingent consideration for acquisitions	(7,883)	(11,242)
Other, net	(170)	(395)
Net cash provided by (used in) financing activities	1,678	(94,058)
Net increase (decrease) in cash, cash equivalents and restricted cash	11,896	(21,753)
Cash, cash equivalents and restricted cash at beginning of year	170,335	146,505
Cash, cash equivalents and restricted cash at end of period	182,231	124,752
Reconciliation of cash, cash equivalents and restricted cash to the   Condensed Consolidated Balance Sheets:
Cash and cash equivalents	2,749	6,113
Restricted cash	37,320	25,275
Cash equivalents included in funds held for clients	142,162	93,364
Total cash, cash equivalents and restricted cash	$ 182,231	$ 124,752

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Selected Terms Used in Notes to the Condensed Consolidated Financial Statements

ASA – Administrative Service Agreement

ASC – Accounting Standards Codification

ASU – Accounting Standards Update

CECL– Current expected credit losses

CPA firm – Certified Public Accounting firm

FASB – The Financial Accounting Standards Board

GAAP – United States Generally Accepted Accounting Principles

LIBOR – London Interbank Offered Rate

SEC – United States Securities and Exchange Commission

Description of Business: CBIZ, Inc. is a diversified services company which, acting through its subsidiaries, has been providing professional business services since 1996, primarily to small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ, Inc. manages and reports its operations along three practice groups: Financial Services, Benefits and Insurance Services and National Practices. A further description of products and services offered by each of the practice groups is provided in Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements.

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries (“CBIZ”, the “Company”, “we”, “us”, or “our”), after elimination of all intercompany balances and transactions. These unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations or cash flows of CBIZ.

Unaudited Interim Financial Statements: The condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2021.

Use of Estimates: The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

XML

New Accounting Pronouncements

9 Months Ended

Sep. 30, 2021

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements

NEW ACCOUNTING PRONOUNCEMENTS

The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an accounting standard to communicate changes to the FASB codification. We assess and review the impact of all accounting standards. Any accounting standards not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements of the Company.

Accounting Standards Issued But Not Yet Adopted

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities through December 31, 2022. We are currently evaluating the effect of this new standard on our consolidated financial statements and have not adopted any of the transition relief available under the new guidance as of September 30, 2021.

Subsequently, in January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which provides optional temporary guidance for entities transitioning away from the LIBOR and other interbank offered rates to new reference rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. This ASU clarifies that the derivative instruments affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions provided in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments provided in this ASU do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship. We are currently evaluating the effect of this new standard on our consolidated financial statements and have not adopted any of the transition relief available under the new guidance as of September 30, 2021.

XML

Accounts Receivable, Net

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

Accounts Receivable, Net

ACCOUNTS RECEIVABLE, NET

Accounts receivable, less allowance for doubtful accounts, reflects the net realizable value of receivables and approximates fair value. Unbilled revenue is recorded at estimated net realizable value. Assessing the collectability of the receivables (billed and unbilled) requires management judgment based on a combination of factors, including but not limited to, an evaluation of our historical incurred loss experience, credit-worthiness of our clients, age of the trade receivable balance, current economic conditions that may affect a client’s ability to pay, and reasonable and supportable forecasts. Receivables are charged-off against the allowance when the balance is deemed uncollectible.

Accounts receivable, net, at September 30, 2021 and December 31, 2020 was as follows (in thousands):

	September 30, 2021		December 31, 2020
Trade accounts receivable	$	200,584	$	167,575
Unbilled revenue, at net realizable value	107,664		63,494
Total accounts receivable	308,248		231,069
Allowance for doubtful accounts	(14,358)		(14,894)
Accounts receivable, net	$	293,890	$	216,175

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2021 and twelve months ended December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Balance at beginning of period	$	(14,894)	$	(14,379)
Provision	(4,450)		(9,323)
Charge-offs, net of recoveries	4,986		8,808
Allowance for doubtful accounts	$	(14,358)	$	(14,894)

XML

Debt and Financing Arrangements

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Debt and Financing Arrangements

DEBT AND FINANCING ARRANGEMENTS

2018 Credit Facility - Our primary financing arrangement is the $400 million unsecured credit facility (the “2018 credit facility” or the “credit facility”), which provides us with the capital necessary to meet our working capital needs as well as the flexibility to continue with our strategic initiatives, including business acquisitions and share repurchases. The 2018 credit facility matures in 2023. The balance outstanding under the 2018 credit facility was $190.2 million and $108.0 million at September 30, 2021 and December 31, 2020, respectively. Effective interest rates, including the impact of interest rate swaps associated with the 2018 credit facility, were as follows:

	Nine Months Ended September 30,
	2021	2020
Weighted average rates	1.89%	2.46%
Range of effective rates	1.06% - 3.64%	1.10% - 4.75%

We had approximately $201.6 million of available funds under the credit facility at September 30, 2021, net of outstanding letters of credit of $3.4 million. As of September 30, 2021, we were in compliance with our financial debt covenants.

Other Line of Credit - We have an unsecured $20.0 million line of credit by and among CBIZ Benefits and Insurance, Inc. and Huntington National Bank. We utilize this line to support our short-term funding requirements of payroll client fund obligations due to the investment of client funds, rather than liquidating client funds that have already been invested in available-for-sale securities. The line of credit, which was renewed on August 5, 2021 and will terminate on August 4, 2022, did not have a balance outstanding at September 30, 2021.

Refer to our Annual Report on Form 10-K for the year ended December 31, 2020 for additional details of our debt and financing arrangements.

Interest Expense - Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, was as follows (in thousands):

	Three Months Ended September 30,
	2021		2020
2018 credit facility	$	1,010	$	955
Other	6		19
Total	$	1,016	$	974

	Nine Months Ended September 30,
	2021		2020
2018 credit facility	$	2,833	$	4,112
Other line of credit	—		1
Other	19		54
Total	$	2,852	$	4,167

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Letters of Credit and Guarantees - We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $3.4 million and $1.7 million at September 30, 2021 and December 31, 2020, respectively. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.3 million and $2.2 million at September 30, 2021 and December 31, 2020, respectively.

Legal Proceedings - In 2010, CBIZ, Inc. and its subsidiary, CBIZ MHM, LLC (formerly, CBIZ Accounting, Tax & Advisory Services, LLC) (the “CBIZ Parties”), were named as defendants in lawsuits filed in the U.S. District Court for the District of Arizona and the Superior Court for Maricopa County, Arizona. The federal court case is captioned Robert Facciola, et al v. Greenberg Traurig LLP, et al, and the state court cases are captioned Victims Recovery, LLC v. Greenberg Traurig LLP, et al, Roger Ashkenazi, et al v. Greenberg Traurig LLP, et al, Mary Marsh, et al v. Greenberg Traurig LLP, et al; and ML Liquidating Trust v. Mayer Hoffman McCann, P.C. (“Mayer Hoffman”), et al. Prior to these suits CBIZ MHM, LLC was named as a defendant in Jeffrey C. Stone v. Greenberg Traurig LLP, et al.

These lawsuits arose out of the bankruptcy of Mortgages Ltd., a mortgage lender to developers in the Phoenix, Arizona area. Various other professional firms and individuals not related to the Company were also named defendants in these lawsuits. The lawsuits asserted claims for, among others things, violations of the Arizona Securities Act, common law fraud, and negligent misrepresentation, and sought to hold the CBIZ Parties vicariously liable for Mayer Hoffman’s conduct as Mortgage Ltd.’s auditor, as either a statutory control person under the Arizona Securities Act or a joint venturer under Arizona common law.

On September 27, 2021, the Superior Court for Maricopa County, Arizona, granted the CBIZ Parties' motion to dismiss with prejudice all of the remaining claims being pursued by two plaintiffs from the Ashkenazi lawsuit. Therefore, all litigation related to these matters has been dismissed or settled without payment by the CBIZ Parties.

On December 19, 2016, CBIZ Operations, Inc. (“CBIZ Operations”) was named as a defendant in a lawsuit filed by Zotec Partners, LLC (“Zotec”) in the Marion County Indiana Superior Court.  After various amendments, the lawsuit asserts claims under Indiana law for securities, statutory and common law fraud or deception, unjust enrichment, breach of contract, and vicarious liability against CBIZ Operations and a former employee of CBIZ MMP in connection with the sale of the CBIZ MMP medical billing practice to Zotec. The plaintiff claims that CBIZ Operations had a duty to disclose the fact, unknown to employees of CBIZ Operations at the time of the transaction, that the former employee had a financial arrangement with a Zotec vendor at the time CBIZ Operations sold CBIZ MMP to Zotec. The plaintiff is seeking damages of up to $177.0 million out of the $200.0 million transaction price. Trial was held in October 2021. The jury found in favor of CBIZ on all fraud, contract and other claims before it. Zotec’s remaining claim for Indiana statutory securities fraud and CBIZ’s counterclaim for breach of contract against Zotec will be addressed by the trial Judge at a later date.

We cannot predict the outcome of the above matter or estimate the possible loss or range of possible loss, if any. Although the proceeding is subject to uncertainties inherent in the litigation process and the ultimate disposition of this proceeding is not presently determinable, we intend to vigorously defend this case. In addition to those items disclosed above, we are, from time to time, subject to claims and lawsuits arising in the ordinary course of business.

On June 24, 2021, CBIZ settled the case previously brought by UPMC, d/b/a University of Pittsburgh Medical Center, and a health system it acquired in connection with actuarial services provided by the Company. Under the terms of the settlement, CBIZ paid a total settlement amount of $41.5 million and recorded a settlement loss of $30.5 million.

XML

Financial Instruments

9 Months Ended

Sep. 30, 2021

Investments, All Other Investments [Abstract]

Financial Instruments

FINANCIAL INSTRUMENTSAvailable-For-Sale Debt Securities - In connection with certain services provided by our payroll operations, we collect funds from our clients’ accounts in advance of paying client obligations. These funds held for clients are segregated and invested in accordance with our investment policy, which requires all investments carry an investment grade rating at the time of initial investment. These

investments, primarily consisting of corporate and municipal bonds, are classified as available-for-sale and are included in the “Funds held for clients” line item on the accompanying Condensed Consolidated Balance Sheets. The par value of these investments totaled $27.1 million and $24.9 million at September 30, 2021 and December 31, 2020, respectively, and had maturity or callable dates ranging from October 2021 through November 2025.

At September 30, 2021, unrealized losses on the securities were not material and have not been recognized as a credit loss because the bonds are investment grade quality and management is not required or does not intend to sell prior to an expected recovery in value. The bond issuers continue to make timely principal and interest payments.

The following table summarizes activities related to these investments for the nine months ended September 30, 2021 and the twelve months ended December 31, 2020 (in thousands):

	Nine Months Ended September 30, 2021		Twelve Months Ended December 31, 2020
Fair value at beginning of period	$	25,708	$	60,659
Purchases	13,050		3,447
Redemptions	(6,280)		(22,078)
Maturities	(4,520)		(15,409)
Change in bond premium	874		(857)
Fair market value adjustment	(377)		(54)
Fair value at end of period	$	28,455	$	25,708

In addition to the available-for-sale debt securities discussed above, we also held other depository assets in the amount of $4.8 million as of September 30, 2021. We did not have any depository items at December 31, 2020. Those depository assets are classified as Level 1 in the fair value hierarchy.

Interest Rate Swaps - We utilize interest rate swaps to manage interest rate risk exposure associated with our floating-rate debt under the 2018 credit facility, or the forecasted acquisition of such liability. We do not purchase or hold any derivative instruments for trading or speculative purposes. Refer to the Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion on our interest rate swaps.

During the first quarter of 2021, one interest rate swap expired with a notional value of $10.0 million. As of September 30, 2021, we have three interest rate swaps outstanding. Under the terms of the interest rate swaps, we pay interest at a fixed rate of interest plus applicable margin as stated in the agreement, and receive interest that varies with the one-month LIBOR. The notional value, fixed rate of interest and expiration date of each interest rate swap as of September 30, 2021 was (i) $20.0 million – 1.770% - May 2022, (ii) $15.0 million – 2.640% - June 2023 and (iii) $50.0 million - 0.885% - April 2025. Refer to Note 7, Fair Value Measurements, for additional disclosures regarding fair value measurements.

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying Condensed Consolidated Balance Sheets at September 30, 2021 and December 31, 2020 (in thousands):

	September 30, 2021
	Notional Amount		Fair Value		Balance Sheet Location
Interest rate swap	$	20,000	$	(211)	Other current liability
Interest rate swaps	$	65,000	$	(575)	Other non-current liabilities

	December 31, 2020
	Notional Amount		Fair Value		Balance Sheet Location
Interest rate swap	$	10,000	$	(13)	Other current liability
Interest rate swaps	$	85,000	$	(2,552)	Other non-current liabilities

The following table summarizes the effects of the interest rate swaps on the accompanying Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2021 and 2020 (in thousands):

	Gain (Loss) Recognized in AOCL, net of tax				Loss Reclassified from AOCL into Expense
	Three Months Ended September 30,				Three Months Ended September 30,
	2021		2020		2021		2020
Interest rate swaps	$	66	$	(136)	$	(285)	$	(293)

	Nine Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Interest rate swaps	$	718	$	(1,796)	$	(850)	$	(676)

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

The following table summarizes our assets and (liabilities) at September 30, 2021 and December 31, 2020, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

	Level	September 30, 2021		December 31, 2020
Deferred compensation plan assets	1	$	136,059	$	127,332
Available-for-sale debt securities	1	28,455		25,708
Other depository assets	1	4,834		—
Deferred compensation plan liabilities	1	(136,059)		(127,332)
Interest rate swaps	2	(786)		(2,565)
Contingent purchase price liabilities	3	(84,628)		(54,391)

During the nine months ended September 30, 2021 and 2020, there were no transfers between the valuation hierarchy Levels 1, 2 and 3. The following table summarizes the change in Level 3 fair values of our contingent purchase price liabilities for the nine months ended September 30, 2021 and 2020 (pre-tax basis) (in thousands):

	2021		2020
Beginning balance – January 1	$	(54,391)	$	(32,089)
Additions from business acquisitions	(38,149)		(14,953)
Settlement of contingent purchase price liabilities	9,511		12,854
Change in fair value of contingencies	(336)		612
Change in net present value of contingencies	(1,263)		(532)
Ending balance – September 30	$	(84,628)	$	(34,108)

Contingent purchase price liabilities result from our business acquisitions and are recorded at fair value at the time of acquisition and are presented as “Contingent purchase price liabilities — current” and “Contingent purchase price liabilities — non-current” in the accompanying Condensed Consolidated Balance Sheets. We estimate the fair value of our contingent purchase price liabilities using a probability-weighted discounted cash flow model. This fair value measure is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Fair value measurements characterized within Level 3 of the fair value hierarchy are measured based on unobservable inputs that are supported by little or no market activity and reflect our own assumptions in measuring fair value.

We probability weight risk-adjusted estimates of future performance of acquired businesses, then calculate the contingent purchase price based on the estimates and discount them to present value representing management’s best estimate of fair value. The fair value of the contingent purchase price liabilities is reassessed quarterly based on assumptions provided by practice group leaders and

business unit controllers together with our corporate finance department. Any change in the fair value estimate is recorded in the earnings of that period. Refer to Note 11, Business Combinations, for further discussion of our acquisitions and contingent purchase price liabilities.

The carrying amounts of our cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short maturity of these instruments, and the carrying value of bank debt approximates fair value as the interest rate on the bank debt is variable and approximates current market rates. As a result, the fair value measurement of our bank debt is considered to be Level 2.

XML

Other Comprehensive Income (Loss)

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Other Comprehensive Income (Loss)

OTHER COMPREHENSIVE INCOME (LOSS)

The following table is a summary of other comprehensive income (loss) and discloses the tax impact of each component of other comprehensive income (loss) for the three and nine months ended September 30, 2021 and 2020 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net unrealized loss on available-for-sale    securities, net of income taxes (1)	$	(116)	$	(46)	$	(274)	$	(1)
Net unrealized gain (loss) on interest rate swaps, net of income taxes (2)	281		(136)		1,359		(1,796)
Foreign currency translation	(6)		(4)		(14)		(18)
Total other comprehensive income (loss)	$	159	$	(186)	$	1,071	$	(1,815)

(1)Net of income tax benefit of $44 and $17 for the three months ended September 30, 2021 and 2020, respectively, and net of income tax benefit of $103 and income tax expense of $2 for the nine months ended September 30, 2021 and 2020, respectively.

(2)Net of income tax expense of $90 and income tax benefit of $45 for the three months ended September 30, 2021 and 2020, respectively, and net of income tax expense of $436 and income tax benefit of $579 for the nine months ended September 30, 2021 and 2020, respectively.

XML

Employee Stock Plans

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Employee Stock Plans

EMPLOYEE STOCK PLANS

The 2019 Stock Omnibus Incentive Plan (the “2019 Plan”), which expires in 2029, permits the grant of various forms of stock-based awards. The terms and vesting schedules for the stock-based awards vary by type and date of grant. A maximum of 3.1 million stock options, restricted stock or other stock-based compensation awards may be granted. Shares subject to award under the 2019 Plan may be either authorized but unissued shares of our common stock or treasury shares. Refer to the Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion on the 2019 Plan.

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2021 and 2020 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Stock options	$	581	$	615	$	1,114	$	1,403
Restricted stock units and awards	1,388		1,266		4,214		3,761
Performance share units	936		604		3,031		1,601
Total stock-based compensation expense	$	2,905	$	2,485	$	8,359	$	6,765

Stock Options and Restricted Stock Units and Awards – The following table presents our stock options and restricted stock units and awards activity during the nine months ended September 30, 2021 (in thousands, except per share data):

	Stock Options			Restricted Stock Units and Awards
	Number of Options	Weighted Average Exercise Price Per Share		Number of Shares	Weighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year	1,820	$	15.02	461	$	21.03
Granted	50	$	32.64	174	$	28.62
Exercised or released	(635)	$	11.25	(246)	$	20.00
Expired or canceled	—	$	—	—	$	—
Outstanding at September 30, 2021	1,235	$	17.68	389	$	25.07
Exercisable at September 30, 2021	1,087	$	17.43

(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

CBIZ utilized the Black-Scholes-Merton options pricing model to determine the fair value of stock options on the date of grant. The per-share fair value of stock options granted on August 12, 2021 was $8.10. The following weighted average assumptions were utilized:

	Nine Months Ended September 30, 2021
Expected volatility (1)	27.49%
Expected option life (years) (2)	4.71
Risk-free interest rate (3)	0.74%
Expected dividend yield (4)	—%

(1) The expected volatility assumption was determined based upon the historical volatility of CBIZ's stock price using daily price intervals.

(2) The expected option life was determined based upon CBIZ's historical data using a midpoint scenario, which assumes all options are exercised halfway between the expiration date and the weighted average time it takes the option to vest.

(3) The risk-free interest rate assumption was based upon zero-coupon U.S. treasury bonds with a term approximating the expected life of the respective options.

(4) The expected dividend yield assumption was determined in view of CBIZ's historical and estimated dividend payouts. CBIZ does not expect to change its dividend payout policy in the foreseeable future.

Performance Share Units (“PSUs”) – PSUs are earned based on our financial performance over a contractual term of three years and the associated expense is recognized over that period based on the fair value of the award. A three-year cliff vesting schedule of the PSUs is dependent upon the Company’s performance relative to pre-established goals based on an earnings per share target (weighted 70%) and total growth in revenue (weighted 30%). The fair value of PSUs is calculated using the market value of a share of our common stock on the date of grant. For performance achieved above specified levels, the recipient may earn additional shares of stock, not to exceed 200% of the number of PSUs initially granted.

The following table presents our PSU award activity during the nine months ended September 30, 2021 (in thousands, except per share data):

	Performance Share Units	Weighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year	307	$	22.18
Granted	140	$	27.56
Vested	—	$	—
Adjustments for performance results	—	$	—
Canceled	—	$	—
Outstanding at September 30, 2021	447	$	23.86

(1)Represents weighted average market value of the performance share units; PSUs are granted at no cost to the recipients.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share from continuing operations for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data).

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Numerator:
Income from continuing operations	$	21,695	$	20,096	$	80,524	$	78,437
Denominator:
Basic
Weighted average common shares outstanding	52,425		54,403		52,885		54,372
Diluted
Stock options (1)	609		738		692		825
Restricted stock units and awards (1)	155		135		182		192
Contingent shares (2)	37		84		37		84
Diluted weighted average common shares    outstanding (3)	53,226		55,360		53,796		55,473
Basic earnings per share from continuing operations	$	0.41	$	0.37	$	1.52	$	1.44
Diluted earnings per share from continuing operations	$	0.41	$	0.36	$	1.50	$	1.41

(1)A total of 44 thousand and 106 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021, respectively, and a total of 274 thousand and 240 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2020, respectively, as their effect would be anti-dilutive.

(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future considerations have been met. Refer to Note 11, Business Combinations, for further details.

(3)The denominator used in calculating diluted earnings per share did not include 447 thousand performance share units for both the three and nine months ended September 30, 2021, and the denominator used in calculating diluted earnings per share did not include 324 thousand performance share units for both the three and nine months ended September 30, 2020. The performance conditions associated with these performance share units were not met and consequently none of these performance share units were considered as issuable for the three and nine months ended September 30, 2021 and 2020.

XML

Business Combinations

9 Months Ended

Sep. 30, 2021

Business Combinations [Abstract]

Business Combinations

BUSINESS COMBINATIONS

Business Combinations

During the nine months ended September 30, 2021, we completed the following acquisitions:

•Effective January 1, 2021, we acquired substantially all the assets of Middle Market Advisory Group (“MMA”). MMA, based in Englewood, Colorado, is a provider of tax compliance and consulting services to middle market companies and family groups in the real estate, automotive, technology and SAAS, construction, and manufacturing industries. Operating results are reported in the Financial Services practice group.

•Effective April 1, 2021, we acquired substantially all the assets of Wright Retirement Services, LLC ("Wright"). Wright, located in Valdosta, Georgia, specializes in third party administration services for retirement plan sponsors. Operating results are reported in the Benefits and Insurance practice group.

•Effective May 1, 2021, we acquired substantially all of the non-attest assets of Bernston Porter & Company, PLLC ("BP"). BP, based in Bellevue, Washington, is a provider of comprehensive accounting and financial consulting services including tax, forensic, economic and valuation services and transaction services to a wide range of industries with specialities including construction, real estate, hospitality, manufacturing and technology. Operating results are reported in the Financial Services practice group.

•Effective June 1, 2021, we acquired all of the issued and outstanding membership interests of Schramm Health Partners, LLC dba Optumas ("Optumas"). Optumas, based in Scottsdale, Arizona, is a provider of actuarial services to state government health care agencies to assist in the administration of Medicaid programs. Operating results are reported in the Financial Services practice group.

•Effective September 1, 2021, we acquired all of the non-attest assets of Shea Labagh Dobberstein ("SLD"). SLD, based in San Francisco, California, is a provider of professional accounting, tax and advisory services to privately held businesses, individuals and nonprofit organizations. Operating results are reported in the Financial Services practice group.

During the nine months ended September 30, 2020, we completed the following acquisitions:

•Effective February 1, 2020, we acquired substantially all the assets of Alliance Insurance Services, Inc., a provider of insurance and advisory services based in Washington, DC. Operating results are reported in the Benefits and Insurance Services practice group.

•Effective February 1, 2020, we acquired substantially all the assets of Pension Dynamics Company, LLC, a full-service retirement and benefits plan advisor based in Pleasant Hill, California. Operating results are reported in the Benefits and Insurance Services practice group.

•Effective February 1, 2020, we acquired substantially all the assets of Sunshine Systems, a payroll solutions provider based in Massachusetts. Operating results are reported in the Benefits and Insurance Services practice group.

•Effective July 1, 2020, we acquired substantially all the assets of Prince-Wood Insurance, LLC, a provider of financial, insurance and advisory services based in Woodbridge, Virginia. Operating results are reported in the Benefits and Insurance practice group.

•Effective September 1, 2020, we acquired substantially all the assets of ARC Consulting LLC and ARC Placement Group LLC, a provider of financial, insurance and advisory services based in San Francisco, California. Operating results are reported in the Financial Services practice group.

Aggregated annualized revenue is estimated to be approximately $71.9 million and $24.6 million from the aforementioned 2021 and 2020 acquisitions, respectively. Aggregated annualized income before tax is estimated to be approximately $6.1 million and $5.9 million from the aforementioned 2021 and 2020 acquisitions, respectively. Pro forma results of operations for these acquisitions have not been presented because the effects of these acquisitions were not material, either individually or in

aggregate, to our total revenue, income from continuing operations, and net income for the three and nine months ended September 30, 2021 and 2020, respectively.

The following table summarizes the aggregated consideration and preliminary purchase price allocation for the acquisitions completed during the nine months ended September 30, 2021 and 2020, respectively (in thousands):

	2021		2020
Common Stock Issued (number)	207		141
Common Stock Value	$	6,940	$	3,543
Cash Paid	66,051		35,474
Other Payable	—		59
Recorded Contingent Consideration	38,148		16,237
Total Recorded Purchase Price	$	111,139	$	55,313
Other Assets Acquired, net	10,179		1,940
Identifiable Intangible Assets Acquired	40,753		4,807
Goodwill	60,207		48,565
Total Net Assets Acquired	$	111,139	$	55,312
Maximum Potential Contingent Consideration	$	40,126	$	18,736

Provisional estimates of fair value are established at the time of each acquisition and are subsequently reviewed within the first year of operations subsequent to the acquisition date to determine the necessity for adjustments. Fair value estimates were provisional for some of the 2021 acquisitions as of September 30, 2021, primarily related to the value established for certain identifiable intangible assets and contingent purchase price consideration associated with those acquisitions.

The following table summarizes the aggregated goodwill and intangible asset amounts resulting from those acquisitions for the nine months ended September 30, 2021 and 2020, respectively (in thousands):

	Nine Months Ended September 30,
	2021				2020
	Financial Services		Benefits & Insurance		Financial Services		Benefits & Insurance
Goodwill	$	58,409	$	1,798	$	34,766	$	13,799
Client List	38,580		1,290		—		4,070
Other Intangibles	837		46		504		233
Total	$	97,826	$	3,134	$	35,270	$	18,102

Goodwill is calculated as the difference between the aggregated purchase price and the fair value of the net assets acquired. Goodwill represents the value of expected future earnings and cash flows, as well as the synergies created by the integration of the new businesses within our organization, including cross-selling opportunities expected with our Financial Services practice group and the Benefits and Insurance Services practice group, to help strengthen our existing service offerings and expand our market position. Client lists have an expected life of 10 years, and other intangibles, primarily non-compete agreements, have an expected life of 3 years.

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and continent payments made for previous business acquisitions in the three and nine months ended September 30, 2021 and 2020, respectively (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net Expense (Income)	$	846	$	74	$	1,599	$	(80)
Cash Settlement Paid	$	—	$	4,995	$	7,584	$	10,881
Shares Issued (number)	13		0		66		81

Divestitures

Divested operations and assets that do not qualify for the treatment as discontinued operations are recorded as “gain on sale of operations, net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. During the nine months ended September 30, 2021, we sold one business for $9.7 million in the Benefit and Insurance practice group and recorded a gain of $6.4 million.

During the nine months ended September 30, 2020, we recorded a gain of $0.1 million related to a small book of business in the Benefits and Insurance practice group and a small accounting firm in the Financial Services practice group.

XML

Segment Disclosures

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Segment Disclosures

SEGMENT DISCLOSURES

Our business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services and National Practices. The business units have been aggregated based on the following factors: similarity of the products and services provided to clients; similarity of the regulatory environment in which they operate; and similarity of economic conditions affecting long-term performance. The business units are managed along these segment lines. A general description of services provided by each practice group is provided in the table below.

Financial Services	Benefits and Insurance Services	National Practices
Accounting and Tax	Group Health Benefits Consulting	Managed Networking and Hardware Services
Government Healthcare Consulting	Payroll	Healthcare Consulting
Financial Advisory	Property and Casualty
Valuation	Retirement Plan Services
Risk & Advisory Services

Corporate and Other - Included in “Corporate and Other” are operating expenses that are not directly allocated to the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in our non-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs and other various expenses.

Accounting policies of the practice groups are the same as those described in Note 1, Basis of Presentation and Significant Accounting Policies, to the Annual Report on Form 10-K for the year ended December 31, 2020. Upon consolidation, intercompany accounts and transactions are eliminated, thus inter-segment revenue is not included in the measure of profit or loss for the practice groups. Performance of the practice groups is evaluated on income (loss) from continuing operations before income tax expense (benefit) excluding those costs listed above, which are reported as “Corporate and Other”.

Segment information for the three and nine months ended September 30, 2021 and 2020 is presented below. We do not manage our assets on a segment basis, therefore segment assets are not presented below.

The following table disaggregates our revenue by source (in thousands):

	Three Months Ended September 30, 2021
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	187,232	—		—		$	187,232
Core benefits and insurance services	—		83,009		—		83,009
Non-core benefits and insurance services	—		2,788		—		2,788
Managed networking, hardware services	—		—		7,088		7,088
National practices consulting	—		—		2,602		2,602
Total revenue	$	187,232	$	85,797	$	9,690	$	282,719

	Three Months Ended September 30, 2020
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	155,499	—		—		$	155,499
Core benefits and insurance services	—		71,497		—		71,497
Non-core benefits and insurance services	—		2,384		—		2,384
Managed networking, hardware services	—		—		6,592		6,592
National practices consulting	—		—		2,417		2,417
Total revenue	$	155,499	$	73,881	$	9,009	$	238,389

	Nine Months Ended September 30, 2021
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	577,970	—		—		$	577,970
Core benefits and insurance services	—		246,367		—		246,367
Non-core benefits and insurance services	—		9,289		—		9,289
Managed networking, hardware services	—		—		20,952		20,952
National practices consulting	—		—		7,519		7,519
Total revenue	$	577,970	$	255,656	$	28,471	$	862,097

	Nine Months Ended September 30, 2020
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	498,359	—		—		$	498,359
Core benefits and insurance services	—		219,362		—		219,362
Non-core benefits and insurance services	—		8,071		—		8,071
Managed networking, hardware services	—		—		19,748		19,748
National practices consulting	—		—		7,247		7,247
Total revenue	$	498,359	$	227,433	$	26,995	$	752,787

Segment information for the three months ended September 30, 2021 and 2020 was as follows (in thousands):

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	187,232	$	85,797	$	9,690	$	—	$	282,719
Operating expenses	156,178		69,039		8,514		4,597		238,328
Gross margin	31,054		16,758		1,176		(4,597)		44,391
Corporate general and administrative expenses	—		—		—		13,035		13,035
Operating income (loss)	31,054		16,758		1,176		(17,632)		31,356
Other income (expense):
Interest expense	—		—		—		(1,016)		(1,016)
Other income (expense), net	18		(9)		1		(1,143)		(1,133)
Total other income (expense), net	18		(9)		1		(2,159)		(2,149)
Income (loss) from continuing operations before income tax expense	$	31,072	$	16,749	$	1,177	$	(19,791)	$	29,207

	Three Months Ended September 30, 2020
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	155,499	$	73,881	$	9,009	$	—	$	238,389
Operating expenses	129,922		62,013		8,070		4,755		204,760
Gross margin	25,577		11,868		939		(4,755)		33,629
Corporate general and administrative expenses	—		—		—		11,339		11,339
Operating income (loss)	25,577		11,868		939		(16,094)		22,290
Other income (expense):
Interest expense	—		(10)		—		(964)		(974)
Gain (loss) on sale of operations, net	(76)		2		—		—		(74)
Other (expense) income, net	(14)		(36)		—		5,964		5,914
Total other (expense) income, net	(90)		(44)		—		5,000		4,866
Income (loss) from continuing operations before income tax expense	$	25,487	$	11,824	$	939	$	(11,094)	$	27,156

Segment information for the nine months ended September 30, 2021 and 2020 was as follows (in thousands):

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	577,970	$	255,656	$	28,471	$	—	$	862,097
Operating expenses	448,844		203,748		25,542		21,099		699,233
Gross margin	129,126		51,908		2,929		(21,099)		162,864
Corporate general and administrative expenses	—		—		—		41,334		41,334
Legal settlement, net							30,468		30,468
Operating income (loss)	129,126		51,908		2,929		(92,901)		91,062
Other income (expense):
Interest expense	—		—		—		(2,852)		(2,852)
Gain on sale of operations, net	—		6,385		—		—		6,385
Other income, net	310		863		1		10,855		12,029
Total other income, net	310		7,248		1		8,003		15,562
Income (loss) from continuing operations before income tax expense	$	129,436	$	59,156	$	2,930	$	(84,898)	$	106,624

	Nine Months Ended September 30, 2020
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	498,359	$	227,433	$	26,995	$	—	$	752,787
Operating expenses	395,937		188,519		24,343		4,804		613,603
Gross margin	102,422		38,914		2,652		(4,804)		139,184
Corporate general and administrative expenses	—		—		—		32,988		32,988
Operating income (loss)	102,422		38,914		2,652		(37,792)		106,196
Other (expense) income:
Interest expense	—		(30)		—		(4,137)		(4,167)
Gain (loss) on sale of operations, net	(25)		103		—		—		78
Other income, net	32		190		1		3,227		3,450
Total other income (expense), net	7		263		1		(910)		(639)
Income (loss) from continuing operations before income tax expense	$	102,429	$	39,177	$	2,653	$	(38,702)	$	105,557

XML

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSSubsequent to September 30, 2021 we repurchased approximately 0.3 million shares of our common stock in the open market at a total cost of approximately $9.0 million.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Description of Business

Description of Business: CBIZ, Inc. is a diversified services company which, acting through its subsidiaries, has been providing professional business services since 1996, primarily to small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ, Inc. manages and reports its operations along three practice groups: Financial Services, Benefits and Insurance Services and National Practices. A further description of products and services offered by each of the practice groups is provided in Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements.

Basis of Consolidation

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries (“CBIZ”, the “Company”, “we”, “us”, or “our”), after elimination of all intercompany balances and transactions. These unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations or cash flows of CBIZ.

Unaudited Interim Financial Statements

Unaudited Interim Financial Statements: The condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2021.

Use of Estimates

Use of Estimates: The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

New Accounting Pronouncements

NEW ACCOUNTING PRONOUNCEMENTS

The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an accounting standard to communicate changes to the FASB codification. We assess and review the impact of all accounting standards. Any accounting standards not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements of the Company.

Accounting Standards Issued But Not Yet Adopted

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities through December 31, 2022. We are currently evaluating the effect of this new standard on our consolidated financial statements and have not adopted any of the transition relief available under the new guidance as of September 30, 2021.

Subsequently, in January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which provides optional temporary guidance for entities transitioning away from the LIBOR and other interbank offered rates to new reference rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. This ASU clarifies that the derivative instruments affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions provided in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments provided in this ASU do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship. We are currently evaluating the effect of this new standard on our consolidated financial statements and have not adopted any of the transition relief available under the new guidance as of September 30, 2021.

XML

Accounts Receivable, Net (Tables)

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

Schedule of Accounts Receivable, Net

Accounts receivable, net, at September 30, 2021 and December 31, 2020 was as follows (in thousands):

	September 30, 2021		December 31, 2020
Trade accounts receivable	$	200,584	$	167,575
Unbilled revenue, at net realizable value	107,664		63,494
Total accounts receivable	308,248		231,069
Allowance for doubtful accounts	(14,358)		(14,894)
Accounts receivable, net	$	293,890	$	216,175

Schedule of Changes in the Allowance for Doubtful Accounts on Accounts Receivable

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2021 and twelve months ended December 31, 2020 are as follows (in thousands):

	September 30, 2021		December 31, 2020
Balance at beginning of period	$	(14,894)	$	(14,379)
Provision	(4,450)		(9,323)
Charge-offs, net of recoveries	4,986		8,808
Allowance for doubtful accounts	$	(14,358)	$	(14,894)

XML

Debt and Financing Arrangements (Tables)

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Summary of Unsecured Credit Facility

Effective interest rates, including the impact of interest rate swaps associated with the 2018 credit facility, were as follows:

	Nine Months Ended September 30,
	2021	2020
Weighted average rates	1.89%	2.46%
Range of effective rates	1.06% - 3.64%	1.10% - 4.75%

Summary of Recognized Interest Expense

Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, was as follows (in thousands):

	Three Months Ended September 30,
	2021		2020
2018 credit facility	$	1,010	$	955
Other	6		19
Total	$	1,016	$	974

	Nine Months Ended September 30,
	2021		2020
2018 credit facility	$	2,833	$	4,112
Other line of credit	—		1
Other	19		54
Total	$	2,852	$	4,167

XML

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Investments, All Other Investments [Abstract]

Summary of Investments

The following table summarizes activities related to these investments for the nine months ended September 30, 2021 and the twelve months ended December 31, 2020 (in thousands):

	Nine Months Ended September 30, 2021		Twelve Months Ended December 31, 2020
Fair value at beginning of period	$	25,708	$	60,659
Purchases	13,050		3,447
Redemptions	(6,280)		(22,078)
Maturities	(4,520)		(15,409)
Change in bond premium	874		(857)
Fair market value adjustment	(377)		(54)
Fair value at end of period	$	28,455	$	25,708

Summary of Outstanding Interest Rate Swaps

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying Condensed Consolidated Balance Sheets at September 30, 2021 and December 31, 2020 (in thousands):

	September 30, 2021
	Notional Amount		Fair Value		Balance Sheet Location
Interest rate swap	$	20,000	$	(211)	Other current liability
Interest rate swaps	$	65,000	$	(575)	Other non-current liabilities

	December 31, 2020
	Notional Amount		Fair Value		Balance Sheet Location
Interest rate swap	$	10,000	$	(13)	Other current liability
Interest rate swaps	$	85,000	$	(2,552)	Other non-current liabilities

Summary of Effects of Interest Rate Swap

The following table summarizes the effects of the interest rate swaps on the accompanying Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2021 and 2020 (in thousands):

	Gain (Loss) Recognized in AOCL, net of tax				Loss Reclassified from AOCL into Expense
	Three Months Ended September 30,				Three Months Ended September 30,
	2021		2020		2021		2020
Interest rate swaps	$	66	$	(136)	$	(285)	$	(293)

	Nine Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Interest rate swaps	$	718	$	(1,796)	$	(850)	$	(676)

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes our assets and (liabilities) at September 30, 2021 and December 31, 2020, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

	Level	September 30, 2021		December 31, 2020
Deferred compensation plan assets	1	$	136,059	$	127,332
Available-for-sale debt securities	1	28,455		25,708
Other depository assets	1	4,834		—
Deferred compensation plan liabilities	1	(136,059)		(127,332)
Interest rate swaps	2	(786)		(2,565)
Contingent purchase price liabilities	3	(84,628)		(54,391)

Change in Level 3 Fair Values of Contingent Purchase Price Liabilities

During the nine months ended September 30, 2021 and 2020, there were no transfers between the valuation hierarchy Levels 1, 2 and 3. The following table summarizes the change in Level 3 fair values of our contingent purchase price liabilities for the nine months ended September 30, 2021 and 2020 (pre-tax basis) (in thousands):

	2021		2020
Beginning balance – January 1	$	(54,391)	$	(32,089)
Additions from business acquisitions	(38,149)		(14,953)
Settlement of contingent purchase price liabilities	9,511		12,854
Change in fair value of contingencies	(336)		612
Change in net present value of contingencies	(1,263)		(532)
Ending balance – September 30	$	(84,628)	$	(34,108)

XML

Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Summary of Other Comprehensive Loss and Tax Impact

The following table is a summary of other comprehensive income (loss) and discloses the tax impact of each component of other comprehensive income (loss) for the three and nine months ended September 30, 2021 and 2020 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net unrealized loss on available-for-sale    securities, net of income taxes (1)	$	(116)	$	(46)	$	(274)	$	(1)
Net unrealized gain (loss) on interest rate swaps, net of income taxes (2)	281		(136)		1,359		(1,796)
Foreign currency translation	(6)		(4)		(14)		(18)
Total other comprehensive income (loss)	$	159	$	(186)	$	1,071	$	(1,815)

(1)Net of income tax benefit of $44 and $17 for the three months ended September 30, 2021 and 2020, respectively, and net of income tax benefit of $103 and income tax expense of $2 for the nine months ended September 30, 2021 and 2020, respectively.

(2)Net of income tax expense of $90 and income tax benefit of $45 for the three months ended September 30, 2021 and 2020, respectively, and net of income tax expense of $436 and income tax benefit of $579 for the nine months ended September 30, 2021 and 2020, respectively.

XML

Employee Stock Plans (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Awards

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2021 and 2020 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Stock options	$	581	$	615	$	1,114	$	1,403
Restricted stock units and awards	1,388		1,266		4,214		3,761
Performance share units	936		604		3,031		1,601
Total stock-based compensation expense	$	2,905	$	2,485	$	8,359	$	6,765

Schedule of Stock Options, Restricted Stock Units and Awards, and Performance Share Units Award Activity

The following table presents our stock options and restricted stock units and awards activity during the nine months ended September 30, 2021 (in thousands, except per share data):

	Stock Options			Restricted Stock Units and Awards
	Number of Options	Weighted Average Exercise Price Per Share		Number of Shares	Weighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year	1,820	$	15.02	461	$	21.03
Granted	50	$	32.64	174	$	28.62
Exercised or released	(635)	$	11.25	(246)	$	20.00
Expired or canceled	—	$	—	—	$	—
Outstanding at September 30, 2021	1,235	$	17.68	389	$	25.07
Exercisable at September 30, 2021	1,087	$	17.43

(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

The following table presents our PSU award activity during the nine months ended September 30, 2021 (in thousands, except per share data):

	Performance Share Units	Weighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year	307	$	22.18
Granted	140	$	27.56
Vested	—	$	—
Adjustments for performance results	—	$	—
Canceled	—	$	—
Outstanding at September 30, 2021	447	$	23.86

(1)Represents weighted average market value of the performance share units; PSUs are granted at no cost to the recipients.

Schedule of Fair Value Option Award Weighted Average Assumptions Used

The following weighted average assumptions were utilized:

	Nine Months Ended September 30, 2021
Expected volatility (1)	27.49%
Expected option life (years) (2)	4.71
Risk-free interest rate (3)	0.74%
Expected dividend yield (4)	—%

(1) The expected volatility assumption was determined based upon the historical volatility of CBIZ's stock price using daily price intervals.

(2) The expected option life was determined based upon CBIZ's historical data using a midpoint scenario, which assumes all options are exercised halfway between the expiration date and the weighted average time it takes the option to vest.

(3) The risk-free interest rate assumption was based upon zero-coupon U.S. treasury bonds with a term approximating the expected life of the respective options.

(4) The expected dividend yield assumption was determined in view of CBIZ's historical and estimated dividend payouts. CBIZ does not expect to change its dividend payout policy in the foreseeable future.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share from Continuing Operations

The following table sets forth the computation of basic and diluted earnings per share from continuing operations for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data).

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Numerator:
Income from continuing operations	$	21,695	$	20,096	$	80,524	$	78,437
Denominator:
Basic
Weighted average common shares outstanding	52,425		54,403		52,885		54,372
Diluted
Stock options (1)	609		738		692		825
Restricted stock units and awards (1)	155		135		182		192
Contingent shares (2)	37		84		37		84
Diluted weighted average common shares    outstanding (3)	53,226		55,360		53,796		55,473
Basic earnings per share from continuing operations	$	0.41	$	0.37	$	1.52	$	1.44
Diluted earnings per share from continuing operations	$	0.41	$	0.36	$	1.50	$	1.41

(1)A total of 44 thousand and 106 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021, respectively, and a total of 274 thousand and 240 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2020, respectively, as their effect would be anti-dilutive.

(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future considerations have been met. Refer to Note 11, Business Combinations, for further details.

(3)The denominator used in calculating diluted earnings per share did not include 447 thousand performance share units for both the three and nine months ended September 30, 2021, and the denominator used in calculating diluted earnings per share did not include 324 thousand performance share units for both the three and nine months ended September 30, 2020. The performance conditions associated with these performance share units were not met and consequently none of these performance share units were considered as issuable for the three and nine months ended September 30, 2021 and 2020.

XML

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2021

Business Combinations [Abstract]

Aggregated Consideration And Preliminary Purchase Price Allocation

The following table summarizes the aggregated consideration and preliminary purchase price allocation for the acquisitions completed during the nine months ended September 30, 2021 and 2020, respectively (in thousands):

	2021		2020
Common Stock Issued (number)	207		141
Common Stock Value	$	6,940	$	3,543
Cash Paid	66,051		35,474
Other Payable	—		59
Recorded Contingent Consideration	38,148		16,237
Total Recorded Purchase Price	$	111,139	$	55,313
Other Assets Acquired, net	10,179		1,940
Identifiable Intangible Assets Acquired	40,753		4,807
Goodwill	60,207		48,565
Total Net Assets Acquired	$	111,139	$	55,312
Maximum Potential Contingent Consideration	$	40,126	$	18,736

Segment Allocation

The following table summarizes the aggregated goodwill and intangible asset amounts resulting from those acquisitions for the nine months ended September 30, 2021 and 2020, respectively (in thousands):

	Nine Months Ended September 30,
	2021				2020
	Financial Services		Benefits & Insurance		Financial Services		Benefits & Insurance
Goodwill	$	58,409	$	1,798	$	34,766	$	13,799
Client List	38,580		1,290		—		4,070
Other Intangibles	837		46		504		233
Total	$	97,826	$	3,134	$	35,270	$	18,102

Contingent Consideration

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and continent payments made for previous business acquisitions in the three and nine months ended September 30, 2021 and 2020, respectively (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net Expense (Income)	$	846	$	74	$	1,599	$	(80)
Cash Settlement Paid	$	—	$	4,995	$	7,584	$	10,881
Shares Issued (number)	13		0		66		81

XML

Segment Disclosures (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Summary of Disaggregation of Revenue by Source

The following table disaggregates our revenue by source (in thousands):

	Three Months Ended September 30, 2021
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	187,232	—		—		$	187,232
Core benefits and insurance services	—		83,009		—		83,009
Non-core benefits and insurance services	—		2,788		—		2,788
Managed networking, hardware services	—		—		7,088		7,088
National practices consulting	—		—		2,602		2,602
Total revenue	$	187,232	$	85,797	$	9,690	$	282,719

	Three Months Ended September 30, 2020
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	155,499	—		—		$	155,499
Core benefits and insurance services	—		71,497		—		71,497
Non-core benefits and insurance services	—		2,384		—		2,384
Managed networking, hardware services	—		—		6,592		6,592
National practices consulting	—		—		2,417		2,417
Total revenue	$	155,499	$	73,881	$	9,009	$	238,389

	Nine Months Ended September 30, 2021
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	577,970	—		—		$	577,970
Core benefits and insurance services	—		246,367		—		246,367
Non-core benefits and insurance services	—		9,289		—		9,289
Managed networking, hardware services	—		—		20,952		20,952
National practices consulting	—		—		7,519		7,519
Total revenue	$	577,970	$	255,656	$	28,471	$	862,097

	Nine Months Ended September 30, 2020
	Financial Services		Benefits & Insurance		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	498,359	—		—		$	498,359
Core benefits and insurance services	—		219,362		—		219,362
Non-core benefits and insurance services	—		8,071		—		8,071
Managed networking, hardware services	—		—		19,748		19,748
National practices consulting	—		—		7,247		7,247
Total revenue	$	498,359	$	227,433	$	26,995	$	752,787

Summary of Segment Information

Segment information for the three months ended September 30, 2021 and 2020 was as follows (in thousands):

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	187,232	$	85,797	$	9,690	$	—	$	282,719
Operating expenses	156,178		69,039		8,514		4,597		238,328
Gross margin	31,054		16,758		1,176		(4,597)		44,391
Corporate general and administrative expenses	—		—		—		13,035		13,035
Operating income (loss)	31,054		16,758		1,176		(17,632)		31,356
Other income (expense):
Interest expense	—		—		—		(1,016)		(1,016)
Other income (expense), net	18		(9)		1		(1,143)		(1,133)
Total other income (expense), net	18		(9)		1		(2,159)		(2,149)
Income (loss) from continuing operations before income tax expense	$	31,072	$	16,749	$	1,177	$	(19,791)	$	29,207

	Three Months Ended September 30, 2020
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	155,499	$	73,881	$	9,009	$	—	$	238,389
Operating expenses	129,922		62,013		8,070		4,755		204,760
Gross margin	25,577		11,868		939		(4,755)		33,629
Corporate general and administrative expenses	—		—		—		11,339		11,339
Operating income (loss)	25,577		11,868		939		(16,094)		22,290
Other income (expense):
Interest expense	—		(10)		—		(964)		(974)
Gain (loss) on sale of operations, net	(76)		2		—		—		(74)
Other (expense) income, net	(14)		(36)		—		5,964		5,914
Total other (expense) income, net	(90)		(44)		—		5,000		4,866
Income (loss) from continuing operations before income tax expense	$	25,487	$	11,824	$	939	$	(11,094)	$	27,156

Segment information for the nine months ended September 30, 2021 and 2020 was as follows (in thousands):

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	577,970	$	255,656	$	28,471	$	—	$	862,097
Operating expenses	448,844		203,748		25,542		21,099		699,233
Gross margin	129,126		51,908		2,929		(21,099)		162,864
Corporate general and administrative expenses	—		—		—		41,334		41,334
Legal settlement, net							30,468		30,468
Operating income (loss)	129,126		51,908		2,929		(92,901)		91,062
Other income (expense):
Interest expense	—		—		—		(2,852)		(2,852)
Gain on sale of operations, net	—		6,385		—		—		6,385
Other income, net	310		863		1		10,855		12,029
Total other income, net	310		7,248		1		8,003		15,562
Income (loss) from continuing operations before income tax expense	$	129,436	$	59,156	$	2,930	$	(84,898)	$	106,624

	Nine Months Ended September 30, 2020
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	498,359	$	227,433	$	26,995	$	—	$	752,787
Operating expenses	395,937		188,519		24,343		4,804		613,603
Gross margin	102,422		38,914		2,652		(4,804)		139,184
Corporate general and administrative expenses	—		—		—		32,988		32,988
Operating income (loss)	102,422		38,914		2,652		(37,792)		106,196
Other (expense) income:
Interest expense	—		(30)		—		(4,137)		(4,167)
Gain (loss) on sale of operations, net	(25)		103		—		—		78
Other income, net	32		190		1		3,227		3,450
Total other income (expense), net	7		263		1		(910)		(639)
Income (loss) from continuing operations before income tax expense	$	102,429	$	39,177	$	2,653	$	(38,702)	$	105,557

XML

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2021 practiceGroup
Accounting Policies [Abstract]
Number of practice groups	3

XML

Accounts Receivable, Net - Schedule of Accounts Receivables Net (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Trade accounts receivable	$ 200,584	$ 167,575
Unbilled revenue, at net realizable value	107,664	63,494
Total accounts receivable	308,248	231,069
Allowance for doubtful accounts	(14,358)	(14,894)	$ (14,379)
Accounts receivable, net	$ 293,890	$ 216,175

XML

Accounts Receivable, Net - Schedule of Changes in the Allowance for Doubtful Accounts on Accounts Receivable (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ (14,894)	$ (14,379)
Provision	(4,450)	(9,323)
Charge-offs, net of recoveries	4,986	8,808
Allowance for doubtful accounts	$ (14,358)	$ (14,894)

XML

Debt and Financing Arrangements - Additional Information (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Outstanding balance under applicable credit facility	$ 190,200,000	$ 108,000,000
Outstanding letters of credit	3,400,000	1,700,000
Other line of credit
Debt Instrument [Line Items]
Revolving loan commitment	20,000,000
Outstanding line of credit	0
2018 Credit Facility
Debt Instrument [Line Items]
Unsecured credit facility	400,000,000
Outstanding balance under applicable credit facility	190,200,000	$ 108,000,000
Available funds under credit facility	201,600,000
Outstanding letters of credit	$ 3,400,000

XML

Debt and Financing Arrangements - Summary of Unsecured Credit Facility (Details)	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Weighted average rates	1.89%	2.46%
Minimum
Debt Instrument [Line Items]
Range of effective rates	1.06%	1.10%
Maximum
Debt Instrument [Line Items]
Range of effective rates	3.64%	4.75%

XML

Debt and Financing Arrangements - Summary of Recognized Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Total	$ 1,016	$ 974	$ 2,852	$ 4,167
2018 credit facility
Debt Instrument [Line Items]
Total	1,010	955	2,833	4,112
Other line of credit
Debt Instrument [Line Items]
Total			0	1
Other
Debt Instrument [Line Items]
Total	$ 6	$ 19	$ 19	$ 54

XML

Commitments and Contingencies - Letters of Credit and Guarantees (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 3.4	$ 1.7
License bonds outstanding amount	$ 2.3	$ 2.2

XML

Commitments and Contingencies - Legal Proceedings (Details) $ in Thousands			3 Months Ended		9 Months Ended
	Jun. 24, 2021 USD ($)	Dec. 19, 2016 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) plaintiff	Sep. 30, 2020 USD ($)
Commitments And Contingencies [Line Items]
Gain (loss) related to legal settlement			$ 0	$ 0	$ (30,468)	$ 0
Baldino Group
Commitments And Contingencies [Line Items]
Number of plaintiffs | plaintiff					2
CBIZ Operations and a former employee of CBIZ MMP
Commitments And Contingencies [Line Items]
Total transaction price		$ 200,000
CBIZ Operations and a former employee of CBIZ MMP | Maximum
Commitments And Contingencies [Line Items]
Damages sought amount		$ 177,000
University of Pittsburgh Medical Center
Commitments And Contingencies [Line Items]
Settlement amount awarded to other party	$ 41,500
Gain (loss) related to legal settlement	$ (30,500)

XML

Financial Instruments - Available-for-Sale Debt Securities (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Par value of available-for-sale debt securities	$ 27,100,000	$ 24,900,000
Funds held for clients	175,451,000	167,440,000
Certified Deposits and Other Depository Assets
Debt Securities, Available-for-sale [Line Items]
Funds held for clients	$ 4,800,000	$ 0

XML

Financial Instruments - Summary of Investments (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Debt Securities, Available for Sale [Roll Forward]
Fair value at beginning of period	$ 25,708	$ 60,659
Purchases	13,050	3,447
Redemptions	(6,280)	(22,078)
Maturities	(4,520)	(15,409)
Change in bond premium	874	(857)
Fair market value adjustment	(377)	(54)
Fair value at end of period	$ 28,455	$ 25,708

XML

Financial Instruments - Interest Rate Swaps (Details)	Sep. 30, 2021 USD ($) swap
Interest rate swaps
Debt Securities, Available-for-sale [Line Items]
Number of interest rate swaps expired | swap	1
Number of interest rate swaps outstanding | swap	3
Interest rate swap, February 2021 expiration
Debt Securities, Available-for-sale [Line Items]
Notional amount	$ 10,000,000
Interest rate swap, May 2022 expiration
Debt Securities, Available-for-sale [Line Items]
Notional amount	$ 20,000,000
Interest rate swap, fixed interest rate	1.77%
Interest rate swap, June 2023 expiration
Debt Securities, Available-for-sale [Line Items]
Notional amount	$ 15,000,000
Interest rate swap, fixed interest rate	2.64%
Interest rate swap, April 2025 expiration
Debt Securities, Available-for-sale [Line Items]
Notional amount	$ 50,000,000
Interest rate swap, fixed interest rate	0.885%

XML

Financial Instruments - Summary of Outstanding Interest Rate Swaps (Details) - Interest rate swaps - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Other current liability
Derivatives, Fair Value [Line Items]
Notional amount, liability	$ 20,000,000	$ 10,000,000
Fair value, liability	(211,000)	(13,000)
Other non-current liabilities
Derivatives, Fair Value [Line Items]
Notional amount, liability	65,000,000	85,000,000
Fair value, liability	$ (575,000)	$ (2,552,000)

XML

Financial Instruments - Summary of Effects of Interest Rate Swaps (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized in AOCL, net of tax	$ 281	$ (136)	$ 1,359	$ (1,796)
Interest rate swaps
Derivatives, Fair Value [Line Items]
Gain (Loss) Recognized in AOCL, net of tax	66	(136)	718	(1,796)
Loss Reclassified from AOCL into Expense	$ (285)	$ (293)	$ (850)	$ (676)

XML

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan assets	$ 136,059	$ 127,332
Available-for-sale debt securities	28,455	25,708	$ 60,659
Deferred compensation plan liabilities	(136,059)	(127,332)
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan assets	136,059	127,332
Available-for-sale debt securities	28,455	25,708
Other depository assets	4,834	0
Deferred compensation plan liabilities	(136,059)	(127,332)
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swaps	(786)	(2,565)
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent purchase price liabilities	$ (84,628)	$ (54,391)

XML

Fair Value Measurements - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair value measurements, inter-transfers between levels	$ 0	$ 0

XML

Fair Value Measurements - Change in Level 3 Fair Values of Contingent Purchase Price Liabilities (Details) - Contingent purchase price liabilities - Level 3 - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance – January 1	$ (54,391)	$ (32,089)
Additions from business acquisitions	(38,149)	(14,953)
Settlement of contingent purchase price liabilities	9,511	12,854
Change in fair value of contingencies	(336)	612
Change in net present value of contingencies	(1,263)	(532)
Ending balance - June 30	$ (84,628)	$ (34,108)

XML

Other Comprehensive Income (Loss) - Summary of Other Comprehensive Loss and Tax Impact (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Equity [Abstract]
Net unrealized loss on available-for-sale securities, net of income taxes	$ (116)	$ (46)	$ (274)	$ (1)
Net unrealized gain (loss) on interest rate swaps, net of income taxes	281	(136)	1,359	(1,796)
Foreign currency translation	(6)	(4)	(14)	(18)
Total other comprehensive income (loss)	159	(186)	1,071	(1,815)
Unrealized loss on available-for-sale securities, income tax expense (benefit)	(44)	(17)	(103)	2
Unrealized gain (loss) on interest rate swaps, income tax expense (benefit)	$ 90	$ (45)	$ 436	$ (579)

XML

Employee Stock Plans - Additional Information (Details) - shares shares in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2019
Performance shares (in shares)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, remaining contractual term	3 years
Performance share units, vesting period	3 years
Achievement of an earnings per share target	70.00%
Achievement of total growth in revenue	30.00%
Performance shares (in shares) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of initial grant	200.00%
2019 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum stock based compensation awards granted under the plan (in shares)		3.1

XML

Employee Stock Plans - Schedule of Stock-Based Compensation Awards (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock options	$ 581	$ 615	$ 1,114	$ 1,403
Restricted stock units and awards	1,388	1,266	4,214	3,761
Performance share units	936	604	3,031	1,601
Total stock-based compensation expense	$ 2,905	$ 2,485	$ 8,359	$ 6,765

XML

Employee Stock Plans - Schedule of Stock Options Award Activity (Details) - $ / shares shares in Thousands	9 Months Ended
	Sep. 30, 2021
Stock Option Activity
Outstanding at beginning of period (in shares)	1,820
Granted (in shares)	50
Exercised or released (in shares)	(635)
Expired or canceled (in shares)	0
Outstanding at end of period (in shares)	1,235
Exercisable at end of period (in shares)	1,087
Stock Option Weighted Average Exercise Price Per Share
Outstanding at beginning of period (in dollars per share)	$ 15.02
Granted (in dollars per share)	32.64
Exercised or released (in dollars per share)	11.25
Expired or canceled (in dollars per share)	0
Outstanding at end of period (in dollars per share)	17.68
Exercisable at end of period (in dollars per share)	$ 17.43

XML

Employee Stock Plans - Schedule of Restricted Stock Units and Awards Activity (Details) - Restricted Stock Units and Awards shares in Thousands	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Restricted Stock Units and Awards Activity
Outstanding at beginning of period (in shares) | shares	461
Granted (in shares) | shares	174
Exercised or released (in shares) | shares	(246)
Expired or canceled (in shares) | shares	0
Outstanding at end of period (in shares) | shares	389
Restricted Stock Units and Awards Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 21.03
Granted (in dollars per share) | $ / shares	28.62
Exercised or released (in dollars per share) | $ / shares	20.00
Expired or canceled (in dollars per share) | $ / shares	0
Outstanding at end of period (in dollars per share) | $ / shares	$ 25.07

XML

Employee Stock Plans - Schedule of Fair Value Option Award Weighted Average Assumptions Used (Details) - $ / shares		9 Months Ended
	Aug. 12, 2021	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Fair value of stock options granted (in dollars per share)	$ 8.10
Expected volatility		27.49%
Expected option life (years)		4 years 8 months 15 days
Risk-free interest rate		0.74%
Expected dividend yield		0.00%

XML

Employee Stock Plans - Schedule of Performance Share Units Award Activity (Details) - Performance shares (in shares) shares in Thousands	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Performance Share Units Award Activity
Outstanding at beginning of period (in shares) | shares	307
Granted (in shares) | shares	140
Vested (in shares) | shares	0
Adjustments for performance results (in shares) | shares	0
Canceled (in shares) | shares	0
Outstanding at end of period (in shares) | shares	447
Performance Share Units Award Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 22.18
Granted (in dollars per share) | $ / shares	27.56
Vested (in dollars per share) | $ / shares	0
Adjustments for performance results (in dollars per share) | $ / shares	0
Canceled (in dollars per share) | $ / shares	0
Outstanding at end of period (in dollars per share) | $ / shares	$ 23.86

XML

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share for Continuing Operations (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator:
Income from continuing operations	$ 21,695	$ 20,096	$ 80,524	$ 78,437
Basic
Weighted average common shares outstanding (in shares)	52,425	54,403	52,885	54,372
Diluted
Stock options (in shares)	609	738	692	825
Restricted stock units and awards (in shares)	155	135	182	192
Contingent shares (in shares)	37	84	37	84
Diluted weighted average common shares outstanding (in shares)	53,226	55,360	53,796	55,473
Basic earnings per share from continuing operations (in dollars per share)	$ 0.41	$ 0.37	$ 1.52	$ 1.44
Diluted earnings per share from continuing operations (in dollars per share)	$ 0.41	$ 0.36	$ 1.50	$ 1.41
Share-based payment arrangement (in shares)
Dilutive Securities Included And Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Share based awards excluded from the calculation of diluted earnings per share (in shares)	44	274	106	240
Performance shares (in shares)
Dilutive Securities Included And Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Share based awards excluded from the calculation of diluted earnings per share (in shares)	447	324	447	324

XML

Business Combinations - Additional Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($) business	Sep. 30, 2020 USD ($)
Business Acquisition, Contingent Consideration [Line Items]
Annual revenue	$ 71,900	$ 24,600
Annual income before tax	6,100	5,900
Proceeds from sales of divested operations	$ 9,785	651
Benefits and Insurance Services Practice Group
Business Acquisition, Contingent Consideration [Line Items]
Number of businesses sold | business	1
Proceeds from sales of divested operations	$ 9,700
Gain from the sale of its individual wealth management business	$ 6,400	$ 100
Client List
Business Acquisition, Contingent Consideration [Line Items]
Acquired finite-lived intangible assets, useful life	10 years
Other Intangibles
Business Acquisition, Contingent Consideration [Line Items]
Acquired finite-lived intangible assets, useful life	3 years

XML

Business Combinations - Aggregated Consideration And Preliminary Purchase Price Allocation (Details) - Series of Individually Immaterial Business Acquisitions - USD ($) shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition, Contingent Consideration [Line Items]
Common Stock Issued (in shares)	207	141
Common Stock Value	$ 6,940	$ 3,543
Cash Paid	66,051	35,474
Other Payable	0	59
Recorded Contingent Consideration	38,148	16,237
Total Recorded Purchase Price	111,139	55,313
Other Assets Acquired, net	10,179	1,940
Identifiable Intangible Assets Acquired	40,753	4,807
Goodwill	60,207	48,565
Total Net Assets Acquired	111,139	55,312
Maximum Potential Contingent Consideration	$ 40,126	$ 18,736

XML

Business Combinations - Segment Allocation (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Sep. 30, 2020
Financial Services
Business Combination Segment Allocation [Line Items]
Goodwill	$ 58,409	$ 34,766
Total	97,826	35,270
Financial Services | Client List
Business Combination Segment Allocation [Line Items]
Intangibles	38,580	0
Financial Services | Other Intangibles
Business Combination Segment Allocation [Line Items]
Intangibles	837	504
Benefits & Insurance
Business Combination Segment Allocation [Line Items]
Goodwill	1,798	13,799
Total	3,134	18,102
Benefits & Insurance | Client List
Business Combination Segment Allocation [Line Items]
Intangibles	1,290	4,070
Benefits & Insurance | Other Intangibles
Business Combination Segment Allocation [Line Items]
Intangibles	$ 46	$ 233

XML

Business Combinations - Changes in Contingent Purchase Price Consideration (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Combinations [Abstract]
Net Expense (Income)	$ 846	$ 74	$ 1,599	$ (80)
Cash Settlement Paid	$ 0	$ 4,995	$ 7,584	$ 10,881
Shares Issued (number)	13,000	0	66,000	81,000

XML

Segment Disclosures - Additional Information (Details)	9 Months Ended
	Sep. 30, 2021 practiceGroup
Segment Reporting [Abstract]
Number of business units of the company	3

XML

Segment Disclosures - Summary of Disaggregation of Revenue by Source (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Total revenue	$ 282,719	$ 238,389	$ 862,097	$ 752,787
Financial Services
Disaggregation of Revenue [Line Items]
Total revenue	187,232	155,499	577,970	498,359
Benefits & Insurance
Disaggregation of Revenue [Line Items]
Total revenue	85,797	73,881	255,656	227,433
National Practices
Disaggregation of Revenue [Line Items]
Total revenue	9,690	9,009	28,471	26,995
Accounting, tax, advisory and consulting
Disaggregation of Revenue [Line Items]
Total revenue	187,232	155,499	577,970	498,359
Accounting, tax, advisory and consulting | Financial Services
Disaggregation of Revenue [Line Items]
Total revenue	187,232	155,499	577,970	498,359
Accounting, tax, advisory and consulting | Benefits & Insurance
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Accounting, tax, advisory and consulting | National Practices
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Core benefits and insurance services
Disaggregation of Revenue [Line Items]
Total revenue	83,009	71,497	246,367	219,362
Core benefits and insurance services | Financial Services
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Core benefits and insurance services | Benefits & Insurance
Disaggregation of Revenue [Line Items]
Total revenue	83,009	71,497	246,367	219,362
Core benefits and insurance services | National Practices
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Non-core benefits and insurance services
Disaggregation of Revenue [Line Items]
Total revenue	2,788	2,384	9,289	8,071
Non-core benefits and insurance services | Financial Services
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Non-core benefits and insurance services | Benefits & Insurance
Disaggregation of Revenue [Line Items]
Total revenue	2,788	2,384	9,289	8,071
Non-core benefits and insurance services | National Practices
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Managed networking, hardware services
Disaggregation of Revenue [Line Items]
Total revenue	7,088	6,592	20,952	19,748
Managed networking, hardware services | Financial Services
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Managed networking, hardware services | Benefits & Insurance
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Managed networking, hardware services | National Practices
Disaggregation of Revenue [Line Items]
Total revenue	7,088	6,592	20,952	19,748
National practices consulting
Disaggregation of Revenue [Line Items]
Total revenue	2,602	2,417	7,519	7,247
National practices consulting | Financial Services
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
National practices consulting | Benefits & Insurance
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
National practices consulting | National Practices
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,602	$ 2,417	$ 7,519	$ 7,247

XML

Segment Disclosures - Summary of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Revenue	$ 282,719	$ 238,389	$ 862,097	$ 752,787
Operating expenses	238,328	204,760	699,233	613,603
Gross margin	44,391	33,629	162,864	139,184
Corporate general and administrative expenses	13,035	11,339	41,334	32,988
Legal settlement, net	0	0	30,468	0
Operating income	31,356	22,290	91,062	106,196
Other income (expense):
Interest expense	(1,016)	(974)	(2,852)	(4,167)
Gain (loss) on sale of operations, net	0	(74)	6,385	78
Other (expense) income, net	(1,133)	5,914	12,029	3,450
Total other (expense) income, net	(2,149)	4,866	15,562	(639)
Income from continuing operations before income tax    expense	29,207	27,156	106,624	105,557
Financial Services
Segment Reporting Information [Line Items]
Revenue	187,232	155,499	577,970	498,359
Benefits & Insurance
Segment Reporting Information [Line Items]
Revenue	85,797	73,881	255,656	227,433
National Practices
Segment Reporting Information [Line Items]
Revenue	9,690	9,009	28,471	26,995
Operating segments | Financial Services
Segment Reporting Information [Line Items]
Revenue	187,232	155,499	577,970	498,359
Operating expenses	156,178	129,922	448,844	395,937
Gross margin	31,054	25,577	129,126	102,422
Corporate general and administrative expenses	0	0	0	0
Legal settlement, net
Operating income	31,054	25,577	129,126	102,422
Other income (expense):
Interest expense	0	0	0	0
Gain (loss) on sale of operations, net		(76)	0	(25)
Other (expense) income, net	18	(14)	310	32
Total other (expense) income, net	18	(90)	310	7
Income from continuing operations before income tax    expense	31,072	25,487	129,436	102,429
Operating segments | Benefits & Insurance
Segment Reporting Information [Line Items]
Revenue	85,797	73,881	255,656	227,433
Operating expenses	69,039	62,013	203,748	188,519
Gross margin	16,758	11,868	51,908	38,914
Corporate general and administrative expenses	0	0	0	0
Legal settlement, net
Operating income	16,758	11,868	51,908	38,914
Other income (expense):
Interest expense	0	(10)	0	(30)
Gain (loss) on sale of operations, net		2	6,385	103
Other (expense) income, net	(9)	(36)	863	190
Total other (expense) income, net	(9)	(44)	7,248	263
Income from continuing operations before income tax    expense	16,749	11,824	59,156	39,177
Operating segments | National Practices
Segment Reporting Information [Line Items]
Revenue	9,690	9,009	28,471	26,995
Operating expenses	8,514	8,070	25,542	24,343
Gross margin	1,176	939	2,929	2,652
Corporate general and administrative expenses	0	0	0	0
Legal settlement, net
Operating income	1,176	939	2,929	2,652
Other income (expense):
Interest expense	0	0	0	0
Gain (loss) on sale of operations, net		0	0	0
Other (expense) income, net	1	0	1	1
Total other (expense) income, net	1	0	1	1
Income from continuing operations before income tax    expense	1,177	939	2,930	2,653
Corporate and Other
Segment Reporting Information [Line Items]
Revenue	0	0	0	0
Operating expenses	4,597	4,755	21,099	4,804
Gross margin	(4,597)	(4,755)	(21,099)	(4,804)
Corporate general and administrative expenses	13,035	11,339	41,334	32,988
Legal settlement, net			30,468
Operating income	(17,632)	(16,094)	(92,901)	(37,792)
Other income (expense):
Interest expense	(1,016)	(964)	(2,852)	(4,137)
Gain (loss) on sale of operations, net		0	0	0
Other (expense) income, net	(1,143)	5,964	10,855	3,227
Total other (expense) income, net	(2,159)	5,000	8,003	(910)
Income from continuing operations before income tax    expense	$ (19,791)	$ (11,094)	$ (84,898)	$ (38,702)

XML

Subsequent Events (Details) - USD ($) $ in Thousands, shares in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Oct. 29, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Subsequent Event [Line Items]
Share repurchases, value		$ 21,445	$ 3,742	$ 84,883	$ 32,771
Subsequent Event
Subsequent Event [Line Items]
Share repurchases (in shares)	0.3
Share repurchases, value	$ 9,000